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ABSTRACT 
Sheep liver 6-phosphogluconate dehydrogenase (6PGDH) shows a high 
specificity for NADP. Discrimination between NADP and NAD suggests that the 
interactions between the 2’-phosphate and 6PGDH contribute most of the binding 
energy for NADP. The 6-phosphate of 6-phosphogluconate (6PG) is proposed to 
anchor the sugar phosphate in the active site and aid in orientating the substrate for 
catalysis. Crystal structure of the E:Nbr8ADP complex shows that Asn32, Arg33 and 
Thr34 are within hydrogen-bonding distance to the 2’-phosphate of NADP. And 
residues Y191, K260, T262, R287 and R446 are in the vicinity of the 6-phosphate of 
6PG in the E:6PG binary complex. Residues S128 and N187 are within 
hydrogen-bonding distance to both 6PG in the E:6PG binary complex and NADPH in 
the E:NADPH binary complex, suggesting that these two residues may play a dual 
role during the catalytic reaction. In addition, residue H186 also hydrogen bonds to 
NADPH in the E:NADPH binary complex, while in the E:6PG binary complex it is 
within hydrogen-bonding distance to S128 and N187. In this study, alanine 
mutagenesis was used to probe the contribution of each of the eleven residues to 
binding the cofactor/substrate and to catalysis. 
All mutant enzymes in the 2’-phosphate site exhibit an increase in KNADP that 
ranges from 6-fold to 80-fold. A 7-fold increase in the primary kinetic 13C-isotope 
 xvi
effect minus 1 in all mutant enzymes indicates that the decarboxylation step has 
become more rate-limiting. All mutant enzymes in the 6-phosphate site, with the 
exception of T262A exhibit an increase in K6PG that ranges from 5-fold to 800-fold. 
The R287A and R446A mutant enzymes exhibit a dramatic decrease in V/Et (600-fold 
and 300-fold, respectively) as well as in V/K6PGEt (105-fold and 104-fold). All mutant 
enzymes also exhibit at least an order of magnitude increase in 13C-isotope effect 
minus 1, indicating that the decarboxylation step has become more rate-liming. The 
S128A, H186A and N187A mutant enzymes exhibit a decrease in V/Et, ranging from 
7-fold to 67-fold. An increase in K6PG was observed for S128A and H187A mutant 
enzymes. An increased Ki NADPH was measured for all of the mutant enzymes, and all 
mutant enzymes also exhibit an increase in the primary kinetic 13C-isotope effect 
minus 1, indicating that the decarboxylation step has become more rate-limiting. 
Data are consistent with significant roles for N32, R33 and T34 in providing 
binding energy for NADP, and Y191, K260, T262, R287 and R446 in providing the 
binding energy for 6PG. In addition, these residues also likely ensure proper 
orientation of NADP/6PG for catalysis and aid in inducing the conformation change 
that precedes catalysis. Data also suggest that residues S128, H186 and N187 help to 
guide the isomerization of the cofactor and provide binding energy for NADPH. 
 
 1
CHAPTER 1 
 
INTRODUCTION 
 
1.1 Pentose Phosphate Pathway. 
6-Phosphogluconate dehydrogenase (EC 1.1.1.44, 6PGDH) is the third enzyme 
in the pentose phosphate pathway. The pentose phosphate pathway [also called the 
phosphogluconate pathway or the hexose monophosphate (HMP) shunt] is the 
alternate way of glucose oxidation and is the major source of NADPH, the reducing 
power which is involved in utilizing the free energy of metabolite oxidation for 
reductive biosynthesis (1). Many endergonic reactions, such as the reductive 
biosynthesis of fatty acids and cholesterol, as well as photosynthesis, require NADPH 
in addition to ATP. Tissues, such as liver, mammary gland, adipose tissue, and adrenal 
cortex rich in pentose phosphate pathway enzymes are involved in fatty acid and 
cholesterol biosynthesis. Although NADPH and NADH chemically resemble each 
other (these coenzymes differ only by a phosphate group at the 2’-OH group of the 
adenosine ribose of NADPH), they are not metabolically interchangeable. This is 
made possible because the dehydrogenases involved in oxidative and reductive 
metabolism exhibit a high specificity towards their coenzymes. In normal cells, the 
[NAD]/[NADH] ratio is maintained near 1000, which favors metabolite oxidation, 
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while the [NADP]/[NADPH] ratio is near 0.01, which favors metabolite reduction. 
NADPH is also an important factor for maintaining the erythrocyte membrane 
integrity by generating reduced glutathione (GSH), catalyzed by glutathione reductase. 
Another function of the pentose phosphate pathway is to provide ribose phosphate for 
the biosynthesis of nucleic acids as well as nucleotide cofactors (Voet and Voet, 
1995). 
The overall reaction of the pentose phosphate pathway is: 
3G6P + 6NADP + 3H2O 6NADPH + 6H
+ + 3CO2 + 2F6P + GAP  
The pathway can be divided into three stages: oxidative (also called oxidative 
branch; Figure 1-1), isomerization and epimerization, and a series of C-C bond 
cleavage and formations (Stage 2 and 3 are called non-oxidative branch). Only the 
first three oxidative reactions in the first stage are involved in NADPH production. In 
the oxidative reactions stage, glucose-6-phosphate (G6P) is oxidized to 
6-phosphoglucono-δ-lactone by glucose-6-phosphate dehydrogenase (G6PDH) with 
the concomitant reduction of NADP to NADPH. Then, 6-phosphoglucono-δ-lactone 
is hydrolyzed to 6-phosphogluconate (6PG) by the 6-phosphogluconolactonase. 
Finally, 6-phosphogluconate dehydrogenase catalyzes the oxidative decarboxylation 
of 6-phosphogluconate to ribulose-5-phosphate (Ru5P) and CO2 with a second 
NADPH produced. The NADPH produced is used for reductive biosynthesis, while 
 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1. Stage 1 of the Pentose Phosphate Pathway. 6-Phosphogluconate 
Dehydrogenase catalyzes the reversible oxidative decarboxylation of 
6-phosphgluconate to ribulose-5-phosphate and CO2 with the reduction 
of NADP to NADPH. 
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the other product, Ru5P, enters the second stage of the pathway, which is either 
transformed to ribose-5-phosphate (R5P) or shunted back to the glycolytic pathway. 
Flux through the pentose phosphate pathway and the rate of NADPH production is 
controlled by G6PDH, which catalyzes the first step of the pathway. The activity of 
G6PDH is regulated by the NADP concentration. When the cell consumes NADPH, 
NADP concentration rises, and given sufficient glucose, the G6PDH activity 
increases, which stimulates NADPH regeneration (1). We will concentrate on the 
6-phosphogluconate dehydrogenase (6PGDH), which catalyzes the final and 
irreversible step in the oxidative branch of the pathway. 
6PGDH has not been reported to be related to hemolytic syndrome (2), as 
G6PDH does, however, carbamylation of 6PDGH may cause cataract in populations 
with high blood urea (3). 6PGDH from Trypanosoma brucei is suggested to be 
involved in parasitic infections (4). 
 
1.2 6-Phosphogluconate Dehydrogenase. 
6-Phosphogluconate dehydrogenase is the third enzyme in the pentose phosphate 
pathway. It catalyzes the reversible oxidative decarboxylation of 6-phosphogluconate, 
a β–hydroxyacid, to ribulose-5-phosphate and CO2, reducing NADP to NADPH as 
shown in Figure 1-1. However, under physiological condition, the reaction is 
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irreversible. 6PGDH is a member of the β-hydroxyacid oxidative decarboxylases, 
which is a class of pyridine nucleotide-linked dehydrogenases that catalyze the 
oxidative decarboxylation of β-hydroxyacids. Unlike other oxidative decarboxylases, 
such as malic enzyme and isocitrate dehydrogenase (ICDH), 6PGDH from most 
sources is metal ion independent, i.e. it does not require the presence of metal ions for 
activity, and indeed, if the concentrations of mono- and divalent cations e.g. Na+, K+, 
Mg2+,exceed 0.1M, they inhibit enzyme activity. No systematic effect of anions has 
been observed on enzyme activity (5, 6 and 7). 
1.2.1 Kinetic Mechanism. 
Although extensive kinetic studies have been carried out for 6-phosphoglucnoate 
dehydrogenase from different species, including Candida utilis, Cryptococcus 
neoformans, Haemophilus influenzae, Lactococcus, human erythrocyte, 
Schizosaccharomyces pombe, sheep liver and Trypanosoma brucei, the most 
thoroughly studied ones are from C. utilis and sheep liver (4, 8-15). A complete 
kinetic characterization of sheep liver 6PGDH including initial velocity studies, 
product and dead-end inhibition patterns in both reaction directions, and primary 
deuterium isotope effects has been performed (12). The initial velocity patterns in the 
forward reaction direction intersect to the left of the ordinate, suggesting a sequential 
mechanism. The V/Et value of sheep liver 6PGDH is 9.4 s-1, while the Km values for 
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6PG and NADP are 25 µM and 3 µM, respectively. Product inhibition studies 
indicated the presence of E:NADP:Ru5P and E:NADPH:6PG dead-end complexes, 
suggesting a random mechanism. Equal deuterium isotope effects were measured on 
V, V/K6PG and V/KNADP, for sheep liver enzyme, indicating that hydride transfer 
contributes to rate-limitation (12, 16 and 17). Combining all the information, Price 
and Cook proposed that the kinetic mechanism of the sheep liver 6PGDH is rapid 
equilibrium random (Figure 1-2) (12), consistent with the kinetic mechanism 
proposed for the 6PGDH from C. utilis (10). 
The theory and methodology for the application of multiple isotope effects to 
enzyme catalyzed reactions allowed a distinction to be made between a concerted and 
stepwise mechanism and provides estimates of the intrinsic isotope effects on the 
bond-breaking steps (18). Hwang et al. measured primary kinetic deuterium, 13C and 
multiple deuterium/13C isotope effects for the C. utilis and sheep liver enzymes, using 
NADP and APADP as the dinucleotide substrates (19). A decrease in 13(V/K6PG) with 
3-d-6PG compared to 3-h-6PG was observed in all cases, indicating that the hydride 
transfer step is more rate limiting with the deuteriation at C3, and the decarboxylation 
step, i.e. the 13C sensitive step, becomes partially masked, signaling a stepwise 
mechanism with oxidation preceding decarboxylation. 
Based upon the collected isotope effect data, intrinsic isotope effects have been  
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Figure 1-2. The Proposed Rapid Equilibrium Random Kinetic Mechanism for Sheep 
Liver 6PGDH. 
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estimated for Candida 6PGDH, which provides information on transition state 
structure (19). The following range of values was obtained: Dk, 2.9-3.3; Cf, 0.15-1.52; 
Cr, 0.23-0.79; and 13k, 1.027-1.062, where Cf and Cr are the forward and the reverse 
commitments to catalysis, respectively, Dk is the intrinsic primary deuterium isotope 
effect, and 13k is the primary 13C-isotope effect. Although Dk is the best defined 
parameter, which represents the hydride transfer from C3 of 6PG to C4 of the 
nicotinamide ring of NADP, it does not distinguish an early or late transition state for 
hydride transfer according to Westheimer’s theory (20, 21). The range of 1.027-1.062 
for 13k suggests a later transition state for C1-C2 bond cleavage because the 
13C-isotope effect is expected to increase from a value very close to 1 for a very early 
transition state to a value of 1.05-1.07 for a late transition state. The partition ratio for 
the 3-keto-6PG intermediate, which is the ratio of the rates of reduction to 6PG to the 
rate of decarboxylation, represented by Cr is relatively small, suggesting that either an 
increase in the energy barrier for the reduction of 3-keto-6PG intermediate, a decrease 
in the energy barrier for its decarboxylation, or both can exist. 
In 1973, Rippa used 2-deoxy-6-PG as an alternative substrate for sheep liver 
6PGDH. The 2-deoxy-3-keto intermediate is released from the enzyme since the next 
step, decarboxylation, is slow, and the decarboxylation only occurs in the presence of 
NADPH (22). This result is consistent with the proposed step-wise mechanism with 
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hydride transfer preceding decarboxylation. 
The proton inventory method was utilized to obtain information on the number 
and fractionation factor for proton(s) being transferred in the rate-limiting transition 
states. Primary solvent deuterium, multiple solvent deuterium/substrate deuterium and 
multiple solvent/13C isotope effects were measured and suggest the presence of a 
significant medium effect in a step preceding hydride transfer, likely a conformational 
change, and the presence of a kinetic solvent deuterium isotope effect on hydride 
transfer, indicating that proton transfer and hydride transfer occur in the same step 
(23). 
1.2.2 Substrate Specificity. 
    6PGDH is specific for NADP. Sheep liver 6PGDH has a KNADP of about 5µM. 
NAD has been shown to be a poor substrate for the C. utilis enzyme with a Km 1000 
times that for NADP (10). In addition, NAD 3’-phosphate is also a poor substrate. 
Thus, the 2’-phosphate of NADP is critical for optimum binding and/or catalysis. 
Changes at the adenine ring, such as with nicotinamide hypoxanthine dinucleotide 
2’-phosphate and ε–NADP, have little effect on activity. Changes in the nicotinamide 
ring, such as with 3-acetylpyridine adenine dinucleotide 2’-phosphate (APADP) and 
thio-NADP give slight changes in V/Et and V/Kcofactor Et. 
    6PGDH is relatively specific for the 6PG/Ru5P substrate/product pair. The best 
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alternative substrate is 2-deoxy-6PG, in which a proton substitutes the 2-hydroxyl 
group of 6PG. The V/Et in this case is down about 100 fold and the immediate product 
of the reaction is 2-deoxy-3-keto-6PG (3Kd6PG) (22). The C. utilis enzyme can use 
6-phosphomannonic acid (with the stereochemistry at C2 reversed compared to 6PG) 
as a substrate, but with a V/Et 1,000 fold lower than that obtained with 6PG (10). 
Data obtained with these two analogs show the importance of the 2-hydroxyl group in 
the reaction. Changes in the stereochemistry of C3, C4 positions, e.g. 
6-phosphoallonate and 6-phosphogalactonate, as well as changes in the 6-phosphate 
group, e.g. 6-sulfogluconate, eliminate substrate activity. This suggests that these 
positions are critical for optimum enzyme activity. 
1.2.3 Chemical Mechanism. 
6PGDH is classed as a pyridine nucleotide linked dehydrogenase. A general 
acid- general base mechanism has been proposed for this class of enzyme. Since 
6PGDH is slightly different from the typical enzymes in this class by being metal ion 
independent, it became interesting to Cook and his coworkers. 
The hypothesis of a Schiff-base intermediate mechanism was ruled out by 
studies carried out previously (24). In their experiment, H218O was used as a solvent 
exchange probe for the forward reaction direction and [2-18O] Ribulose-5-phosphate 
was prepared as a substrate for the reverse reaction direction. If a Schiff-base 
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intermediate is involved in the decarboxylation step, solvent exchange will occur with 
the C-2 oxygen of the 3-keto intermediate. However, they observed a complete 
retention of the labeled oxygen for the reductive carboxylation and the product of the 
oxidative decarboxylation remained unlabeled. This result excludes the possibility of 
a Schiff-base mechanism. 
The pH dependence of the kinetic parameters of the C. utilis enzyme has been 
investigated and a general acid-general base chemical mechanism has been proposed 
(11) (Figure 1-3). In this mechanism, an active site general base is required to accept a 
proton from the 3-hydroxyl group of 6PG concomitant with a hydride transferring 
from C-3 of 6PG to the coenzyme. The resulting 3-keto-6-PG intermediate is 
decarboxylated to produce the enediol of Ru5P. The same general base shuttles the 
proton between itself and the sugar oxygen throughout the reaction, and ultimately 
accepts it as ribulose is formed. A general acid is needed to assist the tautomerization 
of the enediol of Ru5P to the keto product by protonating the C-1 of the enediol of 
Ru5P. Price and Cook performed the same studies on sheep liver 6PGDH and came to 
a similar conclusion. 
From the crystal structures of sheep liver 6PGDH, the completely conserved 
K183 and Glu190 have been proposed to be the best candidate for general base and 
general acid, respectively (12, 25). The pH profiles yield pK values of about 6 and 8  
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Figure 1-3. The proposed general acid-general base chemical mechanism of 
6-Phosphogluconate Dehydrogenase. 
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(12). If the assignment of acid-base catalytic groups is correct, then K183 should have 
a pK of 8 even though it has to be unprotonated, while E190 has a pK of 6 even 
though it has to be protonated. Therefore Price and Cook proposed reverse 
protonation states between the general acid and the general base for the sheep liver 
6PGDH (12) and this hypothesis is in agreement with the unionized form of Glu190 
hydrogen bonding to the 1-carboxylate of 6PG (25). Although the solution pK of 
lysine and glutamate side chain is 10.5 and 4.5, respectively, the hydrophobic 
environment of the active site will favor neutral species, which will make the 
observed pK possible. 
1.2.4 Structure of 6-Phosphogluconate Dehydrogenase. 
The three-dimensional structures of 6PGDH from several sources, including 
sheep liver, Trypanosoma brucei, and Lactococcus lactis, have been solved by X-ray 
crystallography (15, 25, and 26). 
The crystal structures of sheep liver 6PGDH, including the apo-enzyme, 
enzyme-6PG, enzyme-NADPH binary complexes as well as enzyme-substrate analogs 
have been solved (25). Sheep liver 6PGDH is a homodimer with a subunit molecular 
weight of 51,000. The dimer has molecular two fold symmetry. Each subunit is 
comprised of 482 amino acids and can be divided into three domains: the dinucleotide 
binding domain, the helical domain and the C-terminal tail. The monomeric enzyme 
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structure is depicted in Figure 1-4. 
The dinucleotide binding domain is also called the N-terminal β-α-β domain 
(residues 1-176). This domain has a typical Rossman-fold, which is often found in 
dinucleotide binding protein, followed by a short helix and an additional β-α-β unit 
antiparallel to the first one. The second domain (residues 177-434) is the largest 
domain and it has a repeated five-helix motif, which is almost identical in structure. 
The C-terminal tail (residues 435-482) has a single helix and it penetrates into the 
second subunit. Beyond Gly473, the tail is disordered. The active site resides in the 
bottom of the cleft formed by the first two domains and consists of residues from all 
three domains: the dinucleotide binding domain, the helical domain and the 
C-terminal tail from the other subunit (Figure 1-5), which is not common to other 
β-hydroxyacid oxidative decarboxylases. 
According to the crystallographic studies, there may be conformational changes 
upon binding coenzyme and substrate. By comparing the positional parameters 
between the apo-enzyme and the protein in E:Nbr8ADP 
(nicotinamide-8-bromo-adenine dinucleotide phosphate, the active NADP analog), 
E:2’AMP and E:6PG complexes, Adams et al. suggested that there is little protein 
movement required to accommodate the coenzyme (25). The most prominent change 
is the ordering of the side chain of Arg33, which is disordered in the native enzyme,  
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Figure 1-4. Structure of a Monomer of Sheep Liver 6-Phosphogluconate 
Dehydrogenase. Each monomer has three domains: a dinucleotide 
binding domain, a large helical domain, and a C-terminal tail. 
 16
 
 
 
 
 
 
 
 
Figure 1-5. Structure of the dimer of Sheep Liver 6-Phosphogluconate 
Dehydrogenase. 
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but is visible in all coenzyme difference maps. A small movement of some of the 
residues in two loops: 73-78 and 130-133 is also detected. Upon binding coenzyme, 
the solvent accessibilities of several residues in the binding site are decreased and 
hydrophobic residues are more exposed, which contribute to an exposed hydrophobic 
patch. In the 6PG complex, the substrate binds to the protein with only a small 
movement of protein residues. The removal of the two sulphates and four waters in 
the active site pocket is the most important change. It is suggested that the coenzyme 
undergoes a conformational change upon hydride transfer. The evidence for this 
hypothesis is that the conformations of Nbr8ADP, the active NADP analog, and of 
NADPH differs remarkably when they are in the enzyme. The conformations of the 
adenine, adenine ribose and 2’-phosphate are very similar in the E: Nbr8ADP, 
E:2’AMP and E:NADPH structures and the difference essentially comes from the 
nicotinamide ring. The nicotinamide ring in the E: Nbr8ADP complex is very close to 
syn conformation, while in the E:NADPH structure, the nicotinamide ring flips over. 
This change brings the nicotinamide ring of NADPH closer to the substrate binding 
domain and therefore may affect the binding mode of 6PG. 
The oxidized coenzyme makes contacts only with residues in the coenzyme 
domain, while the reduced coenzyme makes large number of hydrogen bond contacts 
with the protein, including those residues that interact with substrate in the E:6PG 
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complex. If the locations of the nicotinamide rings of Nbr8ADP and NADPH 
represent the positions of the coenzyme prior and after the hydride transfer (27), then 
upon hydride transfer the less bonded NADP is brought to the position where more 
hydrogen bonds could be made. And since the new interactions of the coenzyme are 
with the same protein residues that bind 6PG, then it may displace the substrate and 
therefore facilitate decarboxylation or produce release. This may also explain that 
why the E:NADPH:reduced 6PG ternary complex can not be obtained (25). More 
recently, Cervellati et al. mutated Met13 of sheep liver 6PGDH to valine, isoleucine, 
cysteine, phenylalanine, and glutamine. All the resulting mutant enzymes have a 
decreased affinity for NADP, but not for NADPH (28), with the exception of the 
cysteine mutant. This experiment proved that the binding mode of NADP is different 
from that of NADPH, therefore the flipping of the nicotinamide ring of the coenzyme 
observed from the crystallographic study is real, i.e. the rotation is on the reaction 
pathway, but not due to crystallization effect. Therefore, a modified mechanism with 
hydride transfer accompanied by the rotation of the nicotinamide ring around the 
N-glycosidic bond is proposed (28, Figure 1-6). 
Similar phenomenon that different conformers of bound oxidized and reduced 
coenzyme has been observed in two other NAD-dependent aldehyde dehydrogenases 
and NAD-malic enzyme (29-32). Cervellati et al. proposed that this mechanism may  
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Figure 1-6. Modified Chemical Mechanism for 6-Phosphogluconate Dehydrogenase. 
 20
be common for the pyridine nucleotide-linked oxidative decarboxylases (28). 
1.2.5 Theory on 6-Phosphogluconate Dehydrogenase. 
6PGDH from human erythrocytes has been used to study its mechanism (8). 
Binding studies shows that 1 molecule of the dimeric enzyme binds 2 molecules of 
NADP, but only 1 molecule of NADPH per molecule of enzyme. The binding of 
oxidized and reduced coenzyme are mutually exclusive. The initial velocity kinetic 
and inhibition studies shows a negative co-operativity, which is proposed to be the 
result of the half-site reactivity for 6PGDH. In 1992, Hanau et al. carried out 
experiments with sheep liver 6PGDH, using 2-deoxy-6PG and 1,6-NADPH as 
substrate analogs (33). They suggested that NADPH plays a role in activating the 
decarboxylation reaction. The reason being: (i) the decarboxylation of 3Kd6PG does 
not occur with the enzyme alone, (ii) it does not occur when the concentration of 
NADPH is low or when NADPH is recycled, (iii) it occurs when NADPH is formed 
or added. Then they used periodate-oxidized NADP (oNADP) to inactivate the 
enzyme (33). In the presence of substrate, the inactivation is faster and almost 
complete after the labeling of only one subunit. They proposed that these results not 
only confirm the hypothesis of a ‘half-of-the-sites’ mechanism of action of the 
enzyme, but also suggest that the formation of the ternary complex in one subunit 
causes a conformational change that inactive the other subunit. 
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Figure 1-7. Map of pQE30 vector. The insertion a 1.5 kb 6-Phosphogluconate 
Dehydrogenase cDNA is between the EcoR I-Bam HI sites. 
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1.2.6 Cloning, Sequencing, Expression, and Purification of 6-Phosphogluconate 
Dehydrogenase. 
Previously, several attempts to isolate a cDNA clone of 6PGDH were 
unsuccessful. The cDNA sequence, however, was obtained by PCR amplification and 
a family of overlapping cDNA clones encoding a mature protein of 482 amino acids 
was generated (34). A cDNA of the gene that encode the enzyme from sheep liver was 
obtained using RT-PCR and cloned it into a pBluescript phagemid. An expression 
vector, pKK223-3, was used to subclone the cDNA. Expression and purification 
resulted in copurification of the host 6PGDH (Escherichia coli) with the sheep liver 
recombinant enzyme. Therefore, the cDNA was subcloned into pQE-30, which adds a 
6-membered histidine tag to the N-terminus of 6PGDH (Figure 1-7). The pQE 
plasmids contain an optimized, regulatable promoter/operator element, including the 
E. coli phage T5 promoter and two lac operator sequences. Expression from this 
system is highly efficient and only high level of lac repressor can prevent it. 
M15[pREP4] is used as the host strain, which contains multiple copies of the plasmid 
pREP4, carrying the lacI gene encoding the lac repressor. Expression of the 
recombinant protein from pQE vectors is achieved by addition of 
isopropylthio-β-D-galactoside (IPTG), which physically mimics lactose and can bind 
to the lac repressor, preventing it from binding the lac operator, and therefore induces 
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the expression of the protein. The purification system uses a metal chelate adsorbent, 
Ni-NTA (nitrilo-tri-acetic acid), resin that has extremely high affinity for proteins 
containing several consecutive histidine residues (35). The binding capacity of the 
Ni-NTA resin is approximately 5-10 mg protein per ml of resin. The purified enzyme 
has been characterized and the kinetic parameters within error are identical to those 
measured for the native sheep liver 6PGDH (36). 
 
1.3 Specific Goals of This Study. 
Although the kinetic and chemical mechanism of sheep liver 6PGDH has been 
proposed, the mechanism is not completely understood and the functions of some of 
the important residues still remain unclear. The purpose of this research is to 
investigate the functions of these residues and quantitate their contributions, which 
can help us better understand the mechanism of sheep liver 6PGDH. 
Three groups of active site residues are discussed here. They are Asn32, Arg33, 
and Thr34, hydrogen bonding to the 2’-phosphate of NADP; Tyr191, Lys260, Thr262, 
Arg287 and Arg446, hydrogen bonding to and lining the binding site of 6PG; And 
Ser128, hydrogen bonding to the 1-carboxylate of 6PG; Asn187, responsible for 
binding the 3-hydroxyl group of 6PG and together with His186, Ser128 and Asn187 
hydrogen bonding to the nicotinamide of NADPH. In this research, each of these 
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identified residues was mutated to alanine, one at a time, to eliminate their 
interactions with the coenzyme/substrate. 
The hypothesis of this research can be divided into three parts according to the 
three groups of active site residues and they are: 
1. Asn32, Arg33 and Thr34 are important in providing the binding energy and 
determining the specificity of the enzyme for the cofactor. 
2. Tyr191, Lys260, Thr262, Arg287 and Arg446 are important in binding the 
substrate and/or in catalysis. 
3. Ser128, His186 and Asn187 are important in binding 6PG, NADPH and catalysis. 
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CHAPTER 2 
IMPORTANCE OF THE 2’-PHOSPHATE OF NADP 
 
2.1 Introduction. 
6-Phosphogluconate dehydrogenase (6PGDH1; EC 1.1.1.44) catalyzes the 
reversible oxidative decarboxylation of 6-phosphogluconate (6PG), producing 
ribulose-5-phosphate (Ru5P) and CO2 with the concomitant reduction of NADP to 
NADPH.  The kinetic mechanism is rapid equilibrium random on the basis of a 
complete kinetic characterization of the enzymes from sheep liver and Candida utilis 
(1, 2).  The pH dependence of kinetic parameters indicates a general acid-general 
base chemical mechanism (1, 2), and site-directed mutagenesis studies suggest that 
K183 and E190 are likely the general base and the general acid, respectively (3, 4).  
In this mechanism, the general base (K183) is required to accept a proton from the 
3-hydroxyl group of 6PG concomitant with hydride transfer from C-3 of 6PG to the 
coenzyme.  Reduction of the nicotinamide ring is accompanied by rotating around 
the N-glycosidic bond such that the ring occupies the position formerly occupied by 
the 1-carboxylate of the substrate (5).  The resulting 3-keto-6-phosphogluconate 
intermediate is decarboxylated to produce the enediol of Ru5P with the general base 
used to protonate the carboxyl oxygen.  A general acid (E190) is needed to facilitate 
the tautomerization of the enediol of Ru5P to the keto product (Figure 1-6). 
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6PGDH is specific for the substrate 6PG; the best alternative substrate is 
6-phosphomannonate, which has a V/Et 103-fold lower, and a V/K6PMEt 105-fold 
lower than values obtained with 6PG (21).  The enzyme also has a very high 
specificity toward its cofactor NADP; the V/KNADEt is 105-fold lower than that 
obtained with NADP (7).  Most of the direct interactions between the protein and the 
cofactor are made to the 2’-phosphate (6).  Removal of the 2’-phosphate of NADP 
decreases the affinity more than 1,000-fold (7).  In the structure of the E:Nbr8ADP 
(the active NADP analog) binary complex, the 2’-phosphate interacts with three 
active-site residues that are within hydrogen-bond distance: N32, R33 and T34 (6).  
Multiple sequence alignment of 6PGDH shows that N32 is completely conserved, 
while R33 is replaced by tyrosine in the Bacillus Licheniformis and Bacillus subtilis 
sequences, which can use NAD as a cofactor, and T34 is replaced by serine in some 
species (Figure 2-1).  Data indicate that identical hydrogen-bond potential can be 
retained at residues 32 and 34, while the ionic interaction at residue 33 is likely 
important for binding the 2'-phosphate. 
At least four hydrogen-bonds have been proposed between the 2’-phosphate and 
the three residues discussed above, two of which are contributed by R33; Figure 2-2 
shows these residues in the protein environment.  Mutation of R34 in the 6PGDH 
from Lactococcus lactis (the homolog is R33 in sheep liver 6PGDH) to tyrosine gave  
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Figure 2-1. Multiple Sequence Alignment of 6-Phosphogluconate Dehydrogenase 
Sequences Around Position N32-T34. 
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Figure 2-2. Residues in the Binding Site of 2’-Phosphate of NADP in Sheep Liver 
6-Phosphogluconate Dehydrogenase.  In the figure C is green, N is blue, 
O is red, and P is magenta.  The dashed lines represent potential 
hydrogen bonds between the residues of interest and the cofactor.  The 
numbers above the dashed lines are the distances in Å between the 
hydrogen bond donors.  The figure was created using PyMOL from 
DeLano Scientific LLC (www.pymol.org).  The accession number in 
the PDB is 1PGN for the E:Nbr8ADP structure. 
 33
a mutant enzyme that lost most of its affinity for NADP (700-fold decrease), and used 
NAD as a cofactor, but very poorly (8).  In addition to the three residues discussed 
above, a helix dipole is positioned 5 Å away from the 2’-phosphate and is proposed to 
provide an additional electrostatic interaction with the 2’-phosphate (6). 
In this paper we investigate the role of each of the residues that interact with the 
2’-phosphate of NADP.  Site-directed mutagenesis was used to change N32, R33 
and T34 to A, one at a time.  Initial velocity and isotope effects studies were carried 
out to characterize the mutant enzymes.  Data are consistent with the hypothesis that 
these residues are important in providing the binding energy for the 2’-phsophate of 
NADP.  They also play a role in catalysis in the 6PGDH reaction as a result of 
properly orientating the cofactor as well as 6PG. 
 
2.2 Material and Methods. 
2.2.1. Chemicals and Reagents. 
Oligonucleotide primers for mutagenesis and sequencing were from Biosynthesis, 
GibcoBRL and Invitrogen.  The QuikChange® Site-Directed Mutagenesis kit and 
Pfu polymerase were from Stratagene.  The Geneclean® II kit was from Bio 101, Inc.  
The PerfectPrep® Plasmid Mini kit was from Eppendorf.  The DNA molecular 
ladder was from New England Biolabs.  Restriction endonucleases, deoxynucleoside 
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triphosphates, and protein molecular mass markers were purchased from Gibco-BRL. 
Acetaldehyde, acetate kinase, ADP-agarose resin, ATP, ampicillin, 
glucose-6-phosphate dehydrogenase (G6PDH), hexokinase, kanamycin, lithium 
potassium acetyl phosphate, the trisodium salt of 6PG, NADP, and pyrophosphate 
were from Sigma-Aldrich, Co.  β–D-(3-deutero)-glucose (98 atom %D) was from 
Omicron Biochemicals, Inc.  Ni-NTA agarose resin was purchased from QIAGEN.  
Glycerol and sulfuric acid were from Fisher-Scientific, Co.  IPTG was from Gold 
Bio Technology (GBT).  Hepes, Bis-Tris, and Ches buffers were from Research 
Organics, Inc.  D2O (99 atom %D) was from Cambridge Isotope Laboratories, Inc.  
All other chemicals were the highest quality available. 
2.2.2 Bacterial Strain and Plasmids. 
The Escherichia coli strain XL1-Blue was used to transform the mutated plasmid 
and M15[pREP4] was the host strain for expression of the mutant proteins.  The 
plasmid pQE-30 was used as both mutagenesis and expression vector. 
2.2.3 Site-Directed Mutagenesis. 
The QuikChange® Site-Directed Mutagenesis kit from Stratagene was used to 
perform site-directed mutagenesis.  Double-stranded DNA prepared from 
recombinant plasmid pPGDH.LC4 (8) was used as a template and the synthetic 
oligonucleotide primers are listed in Table 2-1.  Whole gene sequencing was  
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Table 2-1. Sequence of Oligonucleotide Primers at the 2’-Phosphate Site. 
Subscripts f and r represent forward and reverse primers. 
Mutated codons are in bold. 
N32Af 
N32Ar 
GTGGTCTGTGCTTTTGCTAGG 
GGAGACTGTCCTAGCAAAAGC 
R33Af 
R33Ar 
GTCTGTGCTTTTAATGCGACAGTCTCCAAAG 
CTTTGGAGACTGTCGCATTAAAAGCACAGAC 
T34Af 
T34Ar 
GCTTTTAATAGGGCAGTCTCCAAAGTTG 
CAACTTTGGAGACTGCCCTATTAAAAGC 
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performed for every mutation at the Laboratory for Genomics and Bioinformatics of 
the University of Oklahoma Health Science Center in Oklahoma City.  The resulting 
sequence was compared to that of the wild type 6PGDH using BLAST.  
Successfully mutated plasmids were transformed into M15[pREP14] competent cells, 
the expression host.  Frozen stocks of strains harboring plasmid were stored in 
LB/ampicillin/kanamycin medium containing 15% glycerol at -80 oC. 
2.2.4 Growth and Purification Conditions. 
The bacterial strain containing the mutated plasmid was first grown in 50-200 mL 
LB medium, containing 100 µg/mL ampicillin and 25 µg/mL kanamycin at 37 oC, 
overnight in a water-bath shaker.  The next day, this culture was transferred into 2-10 
liters of LB/Amp/Kan medium and was incubated at 25 oC for 8 hours or until the 
A600 reached 0.6.  IPTG was then added to a final concentration of 1 mM to initiate 
expression.  After 16 hours of growth at 25 oC with shaking, the cells were harvested 
by centrifugation at 5,000 g for 30 minutes.  The cell pellet was resuspended in 4 
volumes of Buffer A (50 mM triethanolamine, 2 mM β–mercaptoethanol, pH 7.5), 
sonicated on ice for 3 minutes, (pulsing 30 seconds with 30 seconds rest) using a 
MISONIX Sonicator® XL, and centrifuged at 25,000 g for 30 minutes.  The 
supernatant was combined with 2-10 mL of Ni-NTA resin pre-equilibrated with 
Buffer A and stirred at 4 oC for 2 hours.  The mixture was then loaded onto a 25 mL 
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column, and the column was washed with 5 volumes of Buffer A containing 20 mM 
imidazole.  Elution made use of an imidazole gradient (0.2-0.4 M, depends upon the 
freshness of the resin).  Protein concentrations were measured for all fractions using 
the method of Bradford (10).  Fractions containing protein were pooled and applied 
to an ADP agarose affinity column, which takes advantage of the NAD/NADP 
binding site in the protein.  Pooled fractions from the Ni-NTA column were applied 
to the ADP agarose column directly, with a flow rate of 2 mL/min.  The column was 
then washed with 10 volumes of Buffer A and protein was eluted with 150 mM 
pyrophosphate buffer, pH 7.5, containing 1 mM EDTA and 2 mM β–mercaptoethanol.  
Fractions were collected and protein concentration was determined by reading the 
absorbance at 280 nm (ε = 62,160 M-1 cm-1 for 6-His tagged 6PGDH).  Fractions 
containing protein were again pooled and concentrated using an Amicon 
ultrafiltration apparatus with a PM-30 semipermeable membrane.  SDS-PAGE was 
performed for wild type and all mutant enzymes to analyze the purity of the protein. 
The wild type and mutant proteins were purified in an identical manner, and all 
enzymes were stored at 4 oC in the same buffer used for elution from the ADP agarose 
column. 
2.2.5 Synthesis of 3-d-6PG. 
3-deutero-glucose was converted to 3-deutero-glucose 6-phosphate enzymatically 
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using hexokinase as described previously (11).  The extent of conversion to the 
product of the reaction was determined by end-point assay using glucose-6-phosphate 
dehydrogenase.  Upon completion of the reaction, the pH of the solution was 
adjusted to 4.5 to denature the enzymes in the mixture and Amicon ultrafiltration was 
used to remove the enzymes.  The resulting solution was treated with acid-washed 
and heat-activated charcoal, stirred for 1 hour and filtered to remove nucleotides and 
Dowex 50W-H+ resin was then used to remove Mg2+.  The solution, containing 
3-d-glucose 6-phosphate, was bromine oxidized to yield the final product 3-d-6PG, 
which was purified as described previously (5).  1H-NMR confirmed deuteration at 
the 3-position. 
2.2.6 Initial Velocity Studies. 
Initial velocity studies were performed using a Beckman DU640 UV/Vis 
spectrophotometer.  The appearance of NADPH (ε340 = 6.22 mM-1 cm-1) was 
monitored over time using 1 cm pathlength semi-micro quartz cuvettes.  The 
temperature was maintained at 25 oC using a Beckman Temperature Controller.  
Initial velocity patterns were measured for all mutant and wild type enzymes in 100 
mM Hepes, pH 7.5, using variable concentrations of 6PG (15-500 µM) and NADP 
(1-3000 µM) dependent on the mutant enzyme.  Initial velocity studies were also 
performed with NAD as the cofactor at saturating concentration of 6PG (40 Km). 
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2.2.7 Primary Deuterium Isotope Effects. 
The concentrations of 3-h-6PG and 3-d-6PG were determined enzymatically in 
triplicate via end-point assay using wild type 6PGDH.  The concentrations from 
three determinations were in agreement within 2%.  Primary deuterium isotope 
effects with 3-d-6PG were obtained for all the mutant enzymes as well as for the wild 
type enzyme by direct comparison of initial velocities (12).  DV and D(V/K6PG) were 
measured in triplicate varying 3-h-6PG or 3-d-6PG at saturating concentrations of 
NADP. 
2.2.8 pH Studies. 
Initial velocity data were obtained as a function of pH under conditions in which 
NADP was varied while 6PG was fixed at saturating level (40 Km).  The pH was 
maintained using the following buffers at 100 mM concentrations: Bis-Tris, 5-6.5; 
Hepes, 6.5-8.5; Ches, 8.5-9.5.  Sufficient overlap was obtained upon changing 
buffers to eliminate buffer effects.  The pH was determined before and after the 
initial velocity measurements. 
2.2.9 13C Kinetic Isotope Effect. 
Isotope effects were measured using the natural abundance of 13C at the C-1 
position of 6PG (13).  Both high conversion (100% reaction, which represents 
12C/13C in the substrate 6PG) and low conversion samples were used to measure the 
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12C/13C isotope ratios in the CO2 produced from the reaction of 3-h-6PG or 3-d-6PG.  
From these ratios, the 13C-kinetic isotope effect was calculated (14). 
For high conversion samples, in 40 mL, the reaction mixtures contained 2 mM 
3-h-6PG or 3-d-6PG, 0.5 mM NADP+ and 10 mM oxidized glutathione.  The low 
conversion reactions contain 6.5 mM 3-h-6PG or 3-d-6PG.  The NADP+ 
concentration was 0.25 mM for the wild type and the T34A mutant enzymes or 2 mM 
for the N32A and R33A mutant enzymes. All low conversion samples contained 5 
mM oxidized glutathione in a final volume of 40 mL.  The pH of the reaction 
solutions was titrated to 7.6, followed by sparging with CO2-free nitrogen overnight.  
Before starting the reactions, aliquots were withdrawn to determine the initial 
concentrations of 6PG by end-point assay in triplicate.  Then the reactions were 
initiated by the addition of 2 units of 6PGDH and 100 units of glutathione reductase 
to recycle NADP for both high and low conversion samples. 
The high conversion samples were allowed to proceed for more than 16 hours and 
end-point assays were used to confirm the completion of the reaction.  For the low 
conversion samples, extents of reaction were monitored by end-point, assaying the 
remaining 6PG.  Reactions were quenched when 50 µmole of CO2 were produced.  
For both high and low conversion samples, 0.2 mL of concentrated sulfuric acid was 
added to quench the reactions and the generated CO2 was isolated by vacuum 
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distillation (15).  Aliquots of the samples were withdrawn after CO2 isolation and 
incubated at pH 8 overnight.  The next day, end-point assays were performed in 
triplicate to determine the exact extent of the low conversion reactions.  Isotopic 
composition of the CO2 was measured on a Finnigan Delta E isotope-ratio mass 
spectrometer in the laboratory of Dr. Michael Engel, Department of Geophysics, 
University of Oklahoma.  All ratios were corrected for 17O according to Craig (16). 
2.2.10 Data Processing. 
Double reciprocal plots were used to analyze the data and all plots and replots 
were linear.  Data were fitted using the appropriate rate equations and programs 
developed by Cleland (17).  Data for substrate saturation curves obtained at a fixed 
concentration of the second substrate were fitted using eq. 1.  Initial velocity patterns 
were fitted using eq. 2.  Deuterium kinetic isotope effect data were fitted using eq. 3.  
In eqs. 1 and 2, v is the initial velocity, V is the maximum velocity, A and B are 
reactant concentrations, Ka and Kb are the Michaelis constants for NADP and 6PG, 
respectively, and Kia is the dissociation constant for E:NADP.  In eq. 3, Fi is the 
fraction of deuterium label in the substrate, and EV and EV/K are the isotope effects 
minus 1 on V and V/K.  The pH dependence of V/K was fitted using eq. 4, while 
that for V was fitted using eq. 5.  In eqs. 4 and 5, y is V or V/K, C is the pH 
independent value of y, H is the hydrogen ion concentration, and K1 and K2 are the 
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acid dissociation constants for enzyme or substrate groups important in a given 
protonation state for optimal binding and/or catalysis. 
Calculation of 13C-kinetic isotope effects was performed according to eq. 6, where 
f is the fraction of completion of the reaction, Rp and R∞ are the 12C/13C isotopic ratios 
for CO2 at partial and complete conversion, respectively.  Isotope ratios, given as 
δ13C, were calculated from eq. 7, where Rsmp and Rstd are 12C/13C isotopic ratios for 
sample and standard, respectively.  The standard for CO2 was calibrated from Pee 
Dee Belemnite with a 12C/13C of 0.0112372 (16). 
 
v = VA
Ka + A
 [1] 
v = VAB
KiaKb + KaB+ Kb A+ AB
 [2] 
v = VA
Ka 1+ FiEV/K( )+ A 1+ FiEV( )  [3] 
log y = log C
1+ H /K1+ K2 / H
 
  
 
   [4] 
log y = log C
1+ H /K1
 
  
 
   [5] 
13 V /K( )= log 1− f( )
log 1− f Rp / R∞[ ]( ) [6] 
δ 13C( )= RsmpRstd − 1
 
  
 
  x 10
3
 [7] 
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2.3 Results. 
2.3.1 Spectral Properties of Mutant Enzymes. 
Far UV CD spectra were recorded for all mutant and wild type enzymes, and all 
were identical after adjusting for protein concentration (data not shown).  In addition, 
identical tryptophan fluorescence emission spectra were obtained for all mutant and 
wild type enzymes upon excitation at 298 nm, indicating that the microenvironment 
of tryptophan residues of the proteins is the same for all enzymes (data not shown).  
There are 16 tryptophan residues in 6PGDH spread throughout the protein structure.  
As a result, there are no major changes in the overall structure of the enzyme resulting 
from the mutation, and changes are restricted to the local area within the active site. 
2.3.2 Kinetic Parameters of the Mutant Enzymes. 
Initial velocity patterns were obtained by measuring the initial rate at pH 7.5 using 
variable concentrations of 6PG (15-500 µM) and NADP (1-1000 µM) dependent on 
the mutant enzyme.  Data are summarized in Table 2-2.  No significant change was 
observed in K6PG or in the V/Et for all three mutant enzymes with respect to the values 
of the wild type enzyme.  KNADP increased from 6-fold to 80-fold for all mutations, 
resulting in a 6- to 80-fold decrease in V/KNADPEt.  Data indicate elimination of 
either asparagine or arginine impairs cofactor binding more than it does when the 
threonine is replaced. 
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With NAD as the cofactor, KNAD increases by more than 1,000-fold compared to 
KNADP; in fact saturation by NAD cannot be achieved, and only V/KNADEt can be 
estimated.  For the wild type enzyme, a value of 6.6 µM-1min-1 is obtained for 
V/KNAD Et, while for the N32A, R33A and T34A mutant enzymes, values of 0.46 
µM-1min-1, 0.29 µM-1min-1 and 2.2 µM-1min-1, respectively, are estimated.  Data 
suggest that substitution of the three residues by alanine do not improve the ability of 
the enzyme to use NAD as a cofactor. 
2.3.3 Kinetic Primary Deuterium Isotope Effects. 
The kinetic isotope effects on V and V/K6PG were measured at saturating NADP 
(40 Km) (Table 2-3).  The isotope effects are smaller than the values obtained with 
the wild type enzyme in all cases, and within error equal to each other, consistent with 
the proposed rapid equilibrium random kinetic mechanism (1). 
2.3.4 13C-Kinetic Isotope Effects. 
Data for 13C-kinetic isotope effects obtained with 3-h-6PH and 3-d-6PG are 
shown in Table 2-3.  For all of the mutant enzymes, the value of 13(V/K6PG)H minus 1 
is at least 7-fold higher than that of the wild type protein.  Deuteration of 6PG 
decreases the observed 13C-kinetic isotope effects in all cases and the equality for a 
stepwise mechanism with oxidation preceding decarboxylation is satisfied within 
error (14). 
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Table 2-2. Summary of the Kinetic Parameters for 6PGDH Wild Type and Mutant 
Enzymesa at the 2’-Phosphate Site. 
aValues are ± S.E. 
bValues are calculated from KNADP, using ∆Go = -RTlnKNADP. 
 
 wt N32A R33A T34A 
V/Et (sec-1) 
KNADP (µM) 
Fold increase 
K6PG (µM) 
Fold increase 
V/KNADPEt (M-1s-1) 
Fold decrease 
∆Go (kcal mole-1)b 
∆∆Go (kcal mole-1)b 
9.4 ± 0.4 
5 ± 1 
 
28 ± 4 
 
1.9 x 106 
 
-7.2 
9.3 ± 0.8 
310 ± 60 
62 
57 ± 1  
2 
3 x 104  
63 
-4.8 
2.4 
10.4 ± 0.1  
383 ± 9  
77 
33.0 ± 0.5  
1 
2.7 x 104  
70 
-4.7 
2.5 
9.9 ± 0.3 
30.0 ± 0.3 
6 
11.0 ± 0.1 
0.5 
3.3 x 105  
6 
-6.2 
1.0 
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 wt N32A R33A T34A 
DV 
D(V/K6PG) 
13(V/K6PG)H 
 
13(V/K6PG)D 
 
pKa (V)d 
d 
pKa (V/K) e 
e 
1.9 ± 0.1b 
1.9 ± 0.1b 
1.0028 
(0.0007)c 
1.0017 
(0.0005) 
6.40 ± 0.04
- 
6.2 ± 0.2 
8.5 ± 0.1 
1.43 ± 0.03
1.5 ± 0.1 
1.0192 
(0.0003) 
1.017 
(0.002) 
6.18 ± 0.03
9.39 ± 0.05
7.3 ± 0.2 
7.7 ± 0.2 
1.43 ± 0.02
1.5 ± 0.1 
1.0183 
(0.0003) 
1.015 
(0.002) 
5.92 ± 0.08
9.6 ± 0.1 
6.9 ± 0.1 
8.3 ± 0.1 
1.4 ± 0.1 
1.6 ± 0.1 
1.0213 
(0.0007) 
1.016 
(0.002) 
6.05 ± 0.05 
- 
7.03 ± 0.06 
8.56 ± 0.07 
 
Table 2-3. Summary of Isotope Effects and pKa Values for Wild Type and Mutant 
6PGDHa at the 2’-Phosphate Site.  
aValues are ± S.E. bFrom ref 9. 
cValues in parenthesis are standard errors for the 13C-kinetic isotope 
effects. dpKa from the V pH profile. 
epKa from the (V/ K) pH profile. 
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2.3.5 pH Dependence of Kinetic Parameters. 
The pH dependence of the kinetic parameters was measured by varying NADP at 
saturating level of 6PG (40 Km).  All of the mutant and the wild type enzymes are 
stable from pH 5.5 to pH 9.5.  For all of the mutant enzymes, a bell shaped pH-rate 
profile with limiting slopes of 1 and -1 was obtained for V/K6PG.  The pH-rate 
profile for V is bell shaped in the case of the N32A and R33A mutant enzymes, while 
that of the wild type and T34A mutant enzymes, decreases only at low pH.  The pKa 
values are summarized in Table 2-3.  The pH-rate profiles for the wild type and 
R33A mutant enzyme are shown in Figure 2-3 and Figure 2-4. 
 
2.4 Discussion. 
The main aim of this research was to determine the importance of residues N32, 
R33 and T34, which interact with the 2’-phosphate of NADP, and their roles in 
providing binding energy.  Site-directed mutagenesis was used to change N32, R33 
and T34 to alanine one at a time to eliminate the interaction between each of the 
residues and the 2’-phosphate of NADP.  Steady-state kinetic parameters and isotope 
effects were measured to determine the effect of the substitutions on 6PGDH’s ability 
to use NADP as a cofactor. 
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Figure 2-3. pH Dependence of Kinetic Parameters for R33A Mutant Enzyme.  
Data were obtained for V (A) and V/KNADP (B). The points shown 
are the experimentally determined values and the curves are 
theoretical based on the using eq. 4 for V/K and 5 for V. 
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Figure 2-4. pH Dependence of Kinetic Parameters for Wild Type 6-PGDH.  Data 
were obtained for V (A) and V/KNADP (B). The points shown are the 
experimentally determined values and the curves are theoretical based 
on the using eq. 4 for V/K and 5 for V. 
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Theory for interpretation of kinetic parameters and isotope effects in the 6PGDH 
reaction has been developed previously and equations are reproduced here for aid in 
data interpretation (5, 11).  The oxidative decarboxylation reaction catalyzed by 
6PGDH is stepwise with oxidation preceding decarboxylation as suggested by 
multiple deuterium/13C kinetic isotope effect studies (11).  Multiple solvent 
deuterium/13C kinetic isotope effect and proton inventory studies indicate the 
presence of an isomerization of the enzyme complex prior to hydride transfer and 
decarboxylation (18).  The kinetic mechanism of 6PGDH can be written: 
 
EAB
EA
EB
E'AB E'XR E'QR
k3B
k4
k3'A
k4'
k5
k6
k7
k8
k9 [8]
 
where A and B represent NADP and 6PG, respectively, and X, Q, and R represent 
3-keto-6PG, ribulose 5-phosphate, and NADPH, respectively.  The rate constants k3 
and k4 are for binding and dissociation of 6PG and k3’ and k4’ are for binding and 
dissociation of NADP, k5 and k6 are for an isomerization of E:NADP:6PG complex, 
k7 and k8 are for forward and reverse hydride transfer, and k9 is the rate constant for 
decarboxylation of the 3-keto intermediate and release of CO2. 
Given the rapid equilibrium nature of the mechanism, central complex 
interconversion is rate-limiting (steps included from EAB to E’QR), and thus k4, k4' > 
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k5. 
The following expressions have been developed. 
 
V =
k7
1+ k6
k5
1+ cVf + cr
 [9] 
V
K6 PG
=
k3k5k7
k4k6
1+ c f + cr
 [10] 
V
KNADP
=
k3'k5k7
k4'k6
1+ k7
k6
+ k8
k9
V
K6 PG
=
k3'k5k7
k4'k6
1+ c f + cr
 [11] 
 
where cVf =
k7
1
k5
+ 1
k9
 
  
 
  
1+ k6
k5
, c f = k7k6
, and cr = k8k9
. 
 
A kinetic deuterium isotope effect is observed on the hydride transfer step, 
depicted by Dk7 and Dk8, which can be related by the equilibrium isotope effect, DKeq 
= Dk7 /Dk8.  Expressions for the primary kinetic deuterium isotope effects are given 
in eqs. 12 and 13. 
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DV =
Dk7 + cVf + DKeq( )cr
1+ cVf + cr
 [12] 
D
V
K6 PG
 
  
 
  =
Dk7 + c f + DKeq( )cr
1+ c f + cr
 [13] 
 
Since DV = D(V/K) (Table 3), cf = cvf and the equation for the isotope effect on V 
(eq.12) is equal to that on V/K, i.e., eq.13.  The rate constant k9 will reflect a 
13C-kinetic isotope effect given by 13k9.  Expressions for the primary kinetic 
13C-kinetic isotope and the multiple 13C/D multiple isotope effect, i.e., the 13C-kinetic 
isotope effect with 3-d-6PG, are given in eqs. 14 and 15. 
 
13
V
K6 PG
 
  
 
  H
=
13k9 + 1+ c fcr
1+ 1+ c f
cr
 [14] 
 
13
V
K6 PG
 
  
 
  D
=
13k9 +
Dk7
cr
DKeq( )
 
 
  
 
 
  1+
c f
Dk7
 
  
 
  
1+
Dk7
cr
DKeq( )
 
 
  
 
 
  1+
c f
Dk7
 
  
 
  
 [15] 
 
where Dk7 is the intrinsic deuterium isotope effect on the hydride transfer step, and 
DKeq is the equilibrium isotope effect on hydride transfer (1.18 for oxidation of a 
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secondary alcohol (20)). 
Since K6PG is the ratio of V and V/K6PG, and KNADP is the ratio of V and V/KNADP 
and taking into account cf = cvf 
 
K6 PG = k4k3
 
  
 
  
k6
k5 + k6
 
  
 
  = Kd 6 PG  [16] 
KNADP = k4'k3'
 
  
 
  
k6
k5 + k6
 
  
 
  = Kd NADP  [17] 
 
where k4/k3 is the Kd of 6PG and k4’/k3’ is the Kd of NADP for the E:NADP:6PG 
complex and k6/(k5 + k6) corrects for the distribution of the central complexes 
between E:NADP:6PG and E’:NADP:6PG.  Therefore, K6PG is the equilibrium 
constant for dissociation of 6PG from E:NADP:6PG and E’:NADP:6PG and KNADP is 
the equilibrium constant for dissociation of NADP from E:NADP:6PG and 
E’:NADP:6PG.  Using the above rate equations, we discuss the results for each of 
the mutant enzyme. 
The key to interpretation of the data obtained for the mutant enzymes lies in 
changes in KNADP, D(V/K6PG) and 13(V/K6PG).  The decrease in KNADP likely results 
from an increase in the net off-rate for NADP from E’:NADP:6PG, k4'k6/(k5 + k6), 
suggesting an increase in k4', k6, or both.  However, since k6/(k5 + k6) is present in 
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both KNADP and K6PG, and no change is observed in the latter, it is k4’ that is increased. 
2.4.1 Kinetic Parameters. 
A significant increase in KNADP has been obtained for all three mutant enzymes.  
The positively charged arginine side chain is thought to help to neutralize the charge 
on the 2’-phosphate; it is also responsible for all the contacts to one face of the 
adenine ring and thus forms one side of its binding pocket, shielding it from solvent 
(6).  Changing arginine to alanine, not surprisingly, decreases the affinity of the 
mutant enzyme for NADP by >70-fold.  A similar phenomenon has been observed 
for glutathione reductase (19), indicating that this interaction may be one of the 
solutions to the problem of determining the specificity of the enzyme for NADP. 
In the case of N32, the amide side chain donates a hydrogen bond to the 
2’-phosphate, and it also interacts with the 3’-hydroxyl of the adenine ribose.  The 
amide of N32 bridges two turns between βA-αa and βB-αb (Figure 2-2), and is also 
within hydrogen-bonding distance of the main chain nitrogen of L10 and the main 
chain carbonyl of T34, forming a hydrogen-bond network (6).  Substitution of 
asparagine with alanine eliminates all of the above interactions, and thus a 60-fold 
decrease in the affinity to NADP is not unexpected.  Similar binding energy is 
provided by residues N32 and R33 (2.4 kcal/mole and 2.5 kcal/mole, respectively).  
T34A exhibits the smallest change in KNADP, indicating this residue does not 
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contribute as much as N32 and R33 in providing the binding energy to NADP.  If a 
simple sum of ∆∆Go values could accurately be used to give the overall ∆Go of 
NADP binding, the three residues together contribute about 78% of the total binding 
energy to NADP, with about 68% derived from N32 and R33.  Although the simple 
sum is not valid, data are consistent with significant roles of N32, R33 and T34 in 
providing the binding energy of NADP. 
2.4.2 pH Studies. 
The pH dependence of the kinetic parameters measured for the wild type enzyme 
in this study is slightly different than the data reported previously.  The maximum 
velocity exhibits a single pK of 6.4, while two pK values of 5.8 and 8.8 were 
suggested in an earlier study, although the decrease at high pH was slight (1, 3).  The 
difference may reflect the difference in purity and stability of the enzyme after ADP 
agarose affinity chromatography, a step not carried out in the earlier study. 
In the V pH-rate profile of the N32A and R33A mutant enzymes, the pK value of 
K183 is shifted to lower pH, 6-6.2, compared to 6.4 for the wt enzyme.  The V/K 
pH-rate profile of all the three mutant enzymes exhibits two pK values, one on the 
acid side and one on the basic side, as observed for the wt enzyme (3).  However, the 
pK values are closer together in the case of the mutant enzymes, largely a result of an 
increase in the observed pK of the group with the pK on the acid side of the profile. 
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The pK values are attributed to E190 (acid side) and K183 (basic side), which serve 
as general acid and general base, respectively, that is, the two groups exist in reverse 
protonation states.  It is suggested that the local environment of the general acid and 
the general base in the mutant enzymes is more hydrophobic than they are in the wild 
type enzyme.  It is difficult to explain the change in the hydrophilicity of the local 
environment unless the structures of the mutant enzymes are available. 
2.4.3 Kinetic Isotope Effects. 
A small decrease in DV and D(V/K) is obtained, while 13(V/K6PG)H minus 1 is 
increased about 6-fold compared to the wt enzyme (Table 3).  Data suggest an 
increase in the reverse rate of the hydride transfer step and a decrease in the rate of 
decarboxylation step.  Using eqs. 12-14, to have a decreased DV, D(V/K), and an 
increased 13(V/K), the reverse commitment to catalysis cr (k8/k9) has to increase, that 
is the partition ratio of the 3-keto-6-phosphogluconate changes to favor 6PG.  Given 
the increase in cr, and in order that V for the mutant enzymes remains unchanged 
compared to that of the WT enzyme, another rate process must increase to 
compensate.  The obvious choice is k7 since k7/k8 determines the equilibrium 
constant for the hydride transfer step, which is unlikely to change as a result of any of 
the mutations. 
We have recently provided evidence that reduction of the nicotinamide is 
 57
accompanied by rotation of the ring about the N-glycosidic bond to a position that 
was occupied by the 1-carboxylate of 6PG (Fig. 1, 5).  The end result would be 
elimination of the interaction between E190 and the 1-carboxylate, facilitating 
decarboxylation, and resulting in the re face of the nicotinamide ring being exposed to 
the active site (the stereochemistry of hydride transfer is to the si face).  It is possible 
that changing the interaction with the 2'-phosphate by eliminating the side chain of 
N32, R33, or T34, decreases the ability of the nicotinamide ring to rotate.  This 
would result in a stabilization of the nicotinamide ring in the optimum position for 
hydride transfer, increasing the partitioning of the 3-keto-6PG toward 6PG compared 
to ribulose 5-phosphate.  This aspect will require further experimentation. 
In retrospect, the results are not surprising, because the three residues mutated 
provide most of the binding energy for NADP.  Removal of any of the three residues 
may result in a positional change of the bound NADP, which may reorientate the 
nicotinamide ring of NADP to a position that disfavors ring rotation, but favors 
hydride transfer. 
In conclusion, the 2’-phosphate of NADP is critical for making most of the 
interactions between the protein and the cofactor, helping position the cofactor for 
hydride transfer and participating in the rotational isomerization of the cofactor after 
reduction, probably by holding the cofactor in position so that the nicotinamide ring 
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can flip into the right location. Destroying the interactions between the 2’-phosphate 
and the protein results in a slower or less efficient rotation. 
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CHAPTER 3 
 
IMPORTANCE OF THE 6-PHOSPHATE OF 6PG 
 
3.1 Introduction. 
6-Phosphogluconate dehydrogenase (6PGDH1; EC 1.1.1.44) catalyzes the 
reversible oxidative decarboxylation of 6-phosphogluconate (6PG), producing 
ribulose-5-phosphate (Ru5P) and CO2 with the concomitant reduction of NADP to 
NADPH.  The kinetic mechanism is rapid equilibrium random on the basis of a 
complete kinetic characterization of the sheep liver enzyme and Candida utilis (1, 2).  
The pH dependence of kinetic parameters indicates a general acid-general base 
chemical mechanism (1, 2), and site-directed mutagenesis (3, 4) studies suggest that 
K183 and E190 are likely the general base and the general acid, respectively.  In this 
mechanism, the general base (K183) is required to accept a proton from the 
3-hydroxyl group of 6PG concomitant with hydride transfer from C-3 of 6PG to the 
coenzyme.  Reduction of the nicotinamide ring is accompanied by rotating around 
the N-glycosidic bond such that the ring occupies the position formerly occupied by 
the 1-carboxylate of the substrate (5).  The resulting 3-keto-6-phosphogluconate 
intermediate is decarboxylated to produce the enediol of Ru5P with the general base 
used to protonate the carboxyl oxygen.  A general acid (E190) is needed to facilitate 
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the tautomerization of the enediol of Ru5P to the keto product (Figure 1-3). 
In the E:6PG binary complex, the 6-phosphate of 6PG is surrounded by five 
active-site residues that are within hydrogen-bond distance: Y191, K260, T262, R287 
and R446 (6).  Multiple sequence alignment of 6PGDH shows that these five 
residues are completely conserved (Figure 3-1) and Figure 3-2 shows these residues 
in the protein environment.  Notably, Lys260 donates a hydrogen bond to the 
6-phosphate from its backbone NH and also provides significant hydrophobic 
interaction to substrate via its side chain.  Arginine 446 is from the C-terminal tail of 
the second subunit and together with Arg287, balances the charge of the phosphate 
and may contribute most to anchoring the substrate.  Mutations were made at 
Arg447 in 6PGDH from Lactococcus lactis (7) (the homolog is Arg446 in sheep liver 
6PGDH) and all the mutants were devoid of enzyme activity, indicating that this 
residue is critical for activity.  Interestingly, Arg287 participates in a hydrogen-bond 
network through water 528 to Glu190 and the 1-carboxyl of 6PG.  It is suggested 
that this network is important in defining the bound conformation of 6PG (6). 
In this chapter we investigate the role of each of the residues that interact with the 
6-phosphate of 6PG.  Site-directed mutagenesis was used to change Y191, K260, 
T262, R287 and R446 to A, one at a time.  Initial velocity and isotope effects studies 
were carried out to characterize the mutant enzymes.  Data are consistent with the  
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Figure 3-1. Multiple Sequence Alignment of 6-Phosphogluconate Dehydrogenase at 
Y191, K260, T262, R287 and R446 Positions. 
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Figure 3-2. Residues in the 6-Phosphate Binding Site of 6PG in Sheep Liver 
6-Phosphogluconate Dehydrogenase. One subunit is shown in blue and 
the second subunit is shown in yellow. The dashed lines represent 
potential hydrogen bonds between the residues of interest and the 
cofactor.  The numbers above the dashed lines are the distances 
between the hydrogen bond donors.  The figure was created using 
PyMOL from DeLano Scientific LLC (www.pymol.org).  The 
accession number in the PDB is 1PGN for the E:Nbr8ADP structure. 
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hypothesis that these residues are important in providing the binding energy for the 
6-phosphate of 6PG.  They also play a role in catalysis in the 6PGDH reaction as a 
result of properly orientating the substrate. 
 
3.2 Material and Methods. 
3.2.1 Chemicals and Reagents. 
Oligonucleotide primers for mutagenesis and sequencing were from 
Biosynthesis, GibcoBRL and Invitrogen.  The QuikChange® Site-Directed 
Mutagenesis kit and Pfu polymerase were from Stratagene.  The Geneclean® II kit 
was from Bio 101, Inc.  The PerfectPrep® Plasmid Mini kit was from Eppendorf.  
The DNA molecular ladder was from New England Biolabs.  Restriction 
endonucleases, deoxynucleoside triphosphates, and protein molecular mass markers 
were purchased from Gibco-BRL. 
Acetaldehyde, acetate kinase, ADP-agarose resin, ATP, ampicillin, 
glucose-6-phosphate dehydrogenase (G6PDH), hexokinase, kanamycin, lithium 
potassium acetyl phosphate, the trisodium salt of 6PG, NADP, and pyrophosphate 
were from Sigma-Aldrich, Co.  β–D-(3-deutero)-glucose (98 atom% D) was from 
Omicron Biochemicals, Inc.  Ni-NTA agarose resin was purchased from QIAGEN.  
Glycerol and sulfuric acid were from Fisher-Scientific, Co.  IPTG was from Gold 
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Bio Technology (GBT).  Hepes, Bis-Tris, and Ches buffers were from Research 
Organics, Inc.  Deuterium oxide (99 atom% D) was from Cambridge Isotope 
Laboratories, Inc.  All other chemicals were the highest quality available. 
3.2.2 Bacterial Strain and Plasmids. 
The Escherichia coli strain XL1-Blue was used to transform the mutated plasmid 
and M15[pREP4] was the host strain for expression of the mutant proteins.  The 
plasmid pQE-30 was used as both mutagenesis and expression vector. 
3.2.3 Site-Directed Mutagenesis. 
The QuikChange® Site-Directed Mutagenesis kit from Stratagene was used to 
perform site-directed mutagenesis.  Double-stranded DNA prepared from 
recombinant plasmid pPGDH.LC4 (8) was used as a template and the synthetic 
oligonucleotide primers are listed in Table 3-1.  Whole gene sequencing was 
performed for every mutation at the Laboratory for Genomics and Bioinformatics of 
the University of Oklahoma Health Science Center in Oklahoma City.  The resulting 
sequence was compared to that of the wild type 6PGDH using BLAST.  
Successfully mutated plasmids were transformed into M15[pREP14] competent cells, 
the expression host.  Frozen stocks of strains harboring plasmid were stored in 
LB/ampicillin/kanamycin medium containing 15% glycerol at -80 oC. 
3.2.4 Growth and Purification Conditions. 
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Table 3-1. Sequences of Oligonucleotide Primers at the 6-Phosphate Site. 
Subscripts f and r represent forward and reverse primers. 
Mutated codons are in bold. 
Y191Af 
Y191Ar 
   GCACAACGGCATAGAGGCCGGGGACATGCAGC 
   GCTGCATGTCCCCGGCCTCTATGCCGTTGTGC 
K260Af 
K260Ar 
   GGACAGCGCAGGGCAGGCGGGCACCGGGAAGTGG 
   CCACTTCCCGGTGCCCGCCTGCCCTGCGCTGTCC 
T262Af 
T262Ar 
   GGGCAGAAGGGCGCCGGGAAGTGGACC 
   GGTCCACTTCCCGGCGCCCTTCTGCCC 
R287Af 
R287Ar 
   GCTGTCTTCGCGGCATGCTTATCATC 
   GATGATAAGCATGCCGCGAAGACAGC 
R446Af 
R446Ar 
   CCTCATCCAGGCTCAGGCCGACTACTTTGGGGCG 
   CGCCCCAAAGTAGTCGGCCTGAGCCTGGATGAGG 
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The bacterial strain containing the mutated plasmid was first grown in 50-200 
mL LB medium, containing 100 µg/mL ampicillin and 25 µg/mL kanamycin at 37 oC, 
overnight in a water-bath shaker.  The next day, this culture was transferred into 2-10 
liters of LB/Amp/Kan medium and was incubated at 25 oC for 8 hours or until the 
A600 reached 0.6.  IPTG was then added to a final concentration of 1 mM to initiate 
expression.  After 16 hours of growth at 25 oC with shaking, the cells were harvested 
by centrifugation at 5,000 g for 30 minutes.  The cell pellet was resuspended in 4 
volumes of Buffer A (50 mM triethanolamine, 2 mM β–mercaptoethanol, pH 7.5), 
sonicated on ice for 3 minutes, (pulsing 30 seconds with 30 seconds rest) using a 
MISONIX Sonicator® XL, and centrifuged at 25,000 g for 30 minutes.  The 
supernatant was combined with 2-10 mL of Ni-NTA resin pre-equilibrated with 
Buffer A and stirred at 4 oC for 2 hours.  The mixture was then loaded onto a 25 mL 
column, and the column was washed with 5 volumes of Buffer A containing 20 mM 
imidazole.  Elution made use of an imidazole gradient (0.2-0.4 M, dependent on the 
freshness of the resin).  Protein concentrations were measured for all fractions using 
the method of Bradford (9).  Fractions containing protein were pooled and applied to 
an ADP-agarose affinity column, which takes advantage of the NADP binding site in 
the protein.  Pooled fractions from the Ni-NTA column were applied to the 
ADP-agarose column directly, with a flow rate of 2 mL/min.  The column was then 
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washed with 10 volumes of Buffer A and protein was eluted with 150 mM 
pyrophosphate buffer, pH 7.5, containing 1 mM EDTA and 2 mM β–mercaptoethanol.  
Fractions were collected and protein concentration was determined by reading the 
absorbance at 280 nm (ε = 62,160 M-1cm-1 for 6-His tagged 6PGDH).  Fractions 
containing protein were again pooled and concentrated using an Amicon 
ultrafiltration apparatus with a PM-30 semipermeable membrane.  SDS-PAGE was 
performed for wild type and all mutant enzymes to analyze the purity of the protein. 
The wild type and mutant proteins were purified in an identical manner, and all 
enzymes were stored at 4 oC in the same buffer used for elution from the 
ADP-agarose column. 
3.2.5 Synthesis of 3-d-6PG. 
3-deutero-glucose was converted to 3-deutero-glucose 6-phosphate 
enzymatically using hexokinase as described previously (10).  The extent of 
conversion to the product of the reaction was determined by end-point assay using 
glucose-6-phosphate dehydrogenase.  Upon completion of the reaction, the pH of the 
solution was adjusted to 4.5 to denature the enzymes in the mixture and Amicon 
ultrafiltration was used to remove the enzymes.  The resulting solution was treated 
with acid-washed and heat-activated charcoal, stirred for 1 hour and filtered to 
remove nucleotides and then Dowex 50W-H+ resin was used to remove Mg2+.  The 
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solution, containing 3-d-glucose 6-phosphate, was bromine oxidized to yield the final 
product 3-d-6PG, which was purified as described previously (5). 
3.2.6 Initial Velocity Studies. 
Initial velocity studies were performed using a Beckman DU640 UV/Vis 
spectrophotometer.  The appearance of NADPH (ε340 = 6.22 mM-1 cm-1) was 
monitored over time using 1 cm pathlength semi-micro quartz cuvettes.  The 
temperature was maintained at 25 oC using a Beckman Temperature Controller.  
Initial velocity patterns were measured for all mutant and wild type enzymes in 100 
mM Hepes, pH 7.5, using variable concentrations of 6PG (15-500 µM) and NADP 
(1-1000 µM) dependent on the mutant enzyme. 
3.2.7 pH Studies. 
Initial velocity data were obtained as a function of pH under conditions in which 
6PG was varied while NADP was fixed at saturating level (40 Km).  The pH was 
maintained using the following buffers at 100 mM concentrations: Bis-Tris, 5-6.5; 
Hepes, 6.5-8.5; Ches, 8.5-9.5.  Sufficient overlap was obtained upon changing 
buffers to eliminate buffer effects.  The pH was determined before and after the 
initial velocity measurements. 
3.2.8 Primary Deuterium Kinetic Isotope Effects. 
The concentrations of 3-h-6PG and 3-d-6PG were determined enzymatically in 
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triplicate by end-point assay using wild type 6PGDH.  The concentrations from three 
determinations were in agreement within 2%.  Primary deuterium isotope effects 
with 3-d-6PG were obtained for all the mutant enzymes as well as for the wild type 
enzyme by direct comparison of initial velocities (11).  DV and D(V/KNADP) were 
obtained in triplicate by varying NADP at saturating levels of either 3-h-6PG or 
3-d-6PG (20 Km), while DV and D(V/K6PG) were measured in triplicate varying 
3-h-6PG or 3-d-6PG at saturating concentrations of NADP (40 Km). 
3.2.9 Solvent Deuterium Kinetic Isotope Effects. 
Initial velocities for the wild type and mutant enzymes were measured in both 
H2O and D2O solutions.  Substrates (NADP, 3-h-6PG and 3-d-6PG) and buffers used 
in D2O solutions were first dissolved in small volume of D2O and lyophilized 
overnight to remove exchangeable protons.  The lyophilized powders were then 
dissolved in D2O to give the desired concentrations and pD was adjusted using either 
DCl or NaOD.  Primary solvent deuterium isotope effects were obtained by direct 
comparison of initial velocities in the pH/pD independent region. 
3.2.10 13C-Kinetic Isotope Effects. 
These effects were measured using the natural abundance of 13C at the C-1 
position of 6PG (12).  Both high conversion (100% reaction, which represents 
12C/13C in substrate) and low conversion samples were used to measure the 12C/13C 
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isotope ratios in the CO2 produced from the reaction of 3-h-6PG or 3-d-6PG.  From 
these ratios, the 13C-kinetic isotope effect was calculated (13). 
For high conversion samples, in 40 mL of H2O or D2O, the reaction mixtures 
contained 2 mM 3-h-6PG or 3-d-6PG, 0.5 mM NADP and 10 mM oxidized 
glutathione.  The low conversion reactions contain 6.5 mM 3-h-6PG or 3-d-6PG for 
the enzymes that have a K6PG close to that of the wild type 6PGDH (28 µM), or 15 
mM, if K6PG was higher.  The NADP concentration was 0.25 mM for enzymes with 
a KNADP about 2 µM or 1mM if KNADP was higher (greater than 20 µM). All low 
conversion samples contained 5 mM oxidized glutathione in a final volume of 40 mL.  
The pH(D) of the reaction solutions was titrated to 7.6, followed by sparging with 
CO2-free nitrogen overnight.  Before starting the reactions, aliquots were withdrawn 
to determine the initial concentrations of 6PG by end-point assay in triplicate.  Then 
the reactions were initiated by the addition of 2 units of 6PGDH and 100 units of 
glutathione reductase to recycle NADP for both high and low conversion samples. 
The high conversion samples were allowed to proceed for more than 16 hours 
and end-point assays were used to confirm the completion of the reaction.  For the 
low conversion samples, extents of reaction were monitored by end-point, assaying 
the remaining 6PG.  Reactions were quenched when 50 µmole of CO2 were 
produced.  For both high and low conversion samples, 0.2 mL of concentrated 
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sulfuric acid was added to quench the reactions and the generated CO2 was isolated 
by vacuum distillation (14).  Aliquots of the samples were withdrawn after the CO2 
isolation and incubated at pH 8 overnight.  The next day, end-point assays were 
performed in triplicate to determine the exact extent of the low conversion reactions.  
Isotopic composition of the CO2 was measured on a Finnigan Delta E isotope-ratio 
mass spectrometer in the laboratory of Dr. Michael Engel, Department of Geophysics, 
University of Oklahoma.  All ratios were corrected for 17O according to Craig (15). 
3.2.11 Nomenclature. 
Isotope effects are expressed using the nomenclature developed by Northrop (20) 
and Cook and Cleland (21).  Deuterium, 13C, and solvent deuterium kinetic isotope 
effects are written with a leading superscript D, 13, or D2O, e.g. a primary deuterium 
isotope effect on V/K is written D(V/K).  Multiple isotope effects are written with a 
leading superscript to depict the isotope varied, and a following subscript to depict the 
fixed isotope, e.g. a solvent deuterium isotope effect measured with deuterated 6PG 
would be written D2O(V/K)D. 
3.2.12 Data Processing. 
Double reciprocal plots were used to analyze the data and all plots and replots 
were linear.  Data were fitted using the appropriate rate equations and programs 
developed by Cleland (16).  Data for substrate saturation curves obtained at a fixed 
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concentration of the second substrate were fitted using eq. 1.  Initial velocity patterns 
were fitted using eq. 2.  Deuterium kinetic isotope effect data in H2O and D2O were 
fitted using eq. 3.  In eqs. 1 and 2, v is the initial velocity, V is the maximum velocity, 
A and B are reactant concentrations, Ka and Kb are the Michaelis constants for NADP 
and 6PG, respectively, and Kia is the dissociation constant for NADP.  In eq. 3, Fi is 
the fraction of deuterium label in the substrate or solvent, and EV and EV/K are the 
isotope effects minus 1 on V and V/K.  The pH dependence of V and V/K were 
fitted using eq. 4, in which y is V or V/K, C is the pH independent value of y, H is the 
hydrogen ion concentration, and K1 and K2 are the acid dissociation constants for 
enzyme or substrate groups important in a given protonation state for optimal binding 
and/or catalysis. 
Calculation of 13C-kinetic isotope effects was performed according to eq. 5, 
where f is the fraction of completion of the reaction, Rp and R∞ are the 12C/13C 
isotopic ratios for CO2 at partial and complete conversion, respectively.  Isotope 
ratios, given as δ13C, were calculated from eq. 6, where Rsmp and Rstd are 12C/13C 
isotopic ratios for sample and standard, respectively.  The standard for CO2 was 
calibrated from Pee Dee Belemnite with a 12C/13C of 0.0112372 (15). 
 
v = VA
Ka + A
  [1] 
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v = VAB
KiaKb + KaB+ Kb A+ AB
  [2] 
v = VA
Ka 1+ FiEV/K( )+ A 1+ FiEV( )   [3] 
log y = log C
1+ H /K1+ K2 / H
 
  
 
    [4] 
13 V /K( )= log 1− f( )
log 1− f Rp / R∞[ ]( )  [5] 
δ 13C( )= RsmpRstd − 1
 
  
 
  x 10
3
   [6] 
 
3.3  Results. 
3.3.1 Spectral Properties of Mutant Enzymes. 
There are 16 tryptophan residues in 6PGDH spread throughout the protein 
structure.  Identical tryptophan fluorescence emission spectra were obtained for all 
mutant and wild type enzymes, upon excitation at 298 nm (data not shown), 
indicating that the microenvironment of tryptophan residues of the proteins is the 
same for all enzymes.  As a result, there are no major changes in the overall 
structure of the enzyme resulting from the mutation. Changes are restricted to the 
local area within the active site.  
3.3.2 Kinetic Parameters of the Mutant Enzymes. 
Initial velocity patterns were obtained by measuring the initial rate at pH 7.5 
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 wt Y191A K260A T262A R287A R446A 
V/Et (sec-1) 
Fold decrease 
KNADP (µM) 
Fold increase 
K6PG (µM) 
Fold increase 
V/K6PGEt (M-1s-1) 
Fold decrease 
∆Go (kcal mole-1)b 
∆∆Go (kcal mole-1)b 
9.4 ± 0.4
 
5 ± 1 
 
28 ± 4 
 
3.4 x 105 
 
-6.2 
11.0 ± 0.4 
- 
14 ± 2 
2.8 
1,040 ± 60 
37 
1.1 x 104 
31 
-4.1 
2.1 
0.43 ± 0.05 
22 
16 ± 3  
3.2 
150 ± 8 
5.4 
2.8 x 103  
121 
-5.2 
1.0 
3.1 ± 0.3 
3 
4.2 ± 0.5 
- 
24 ± 1 
0.9 
1.3 x 105
2.6 
-6.3 
- 
0.015 ± 0.001 
627 
73 ± 10  
15 
23000 ± 2000
814 
0.6  
5.7 x 105 
-2.2 
4.0 
0.03 ± 0.01 
303 
64 ± 6  
13 
3,400 ± 400 
120 
9.2  
3.7 x 104 
-3.4 
2.8 
 
Table 3-2. Summary of the Kinetic Parameters for 6PGDH Wild Type and Mutant Enzymesa at the  
6-Phosphate Site. aValues are ± S.E. 
bValues are calculated from K6PG, using ∆Go = RTlnK6PG. 
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 wt Y191A K260A T262A 
DV 
D(V/K6PG) 
13(V/K6PG)H 
 
13(V/K6PG)D 
 
13(V/K6PG)D2O 
 
D2OVH 
D2O(V/K6PG)H 
D2O(V)D 
D2O(V/K6PG)D 
pKa (V)f 
f 
pKa (V/K) g 
g 
1.9 ± 0.1b 
1.9 ± 0.1 b 
1.0028 
(0.0007)c 
1.0017 
(0.0005) 
- 
- 
2.10 ± 0.05
1.9 ± 0.2 
2.3 ± 0.1 
2.28 ± 0.02
6.40 ± 0.04e
- 
6.2 ± 0.2 e 
8.5 ± 0.1 e 
1.06 ± 0.02
1.05 ± 0.02
1.0269 
(0.0005) 
N.D.d 
 
1.0116  
(0.0005) 
1.58 ± 0.06
1.6 ± 0.1 
- 
- 
6.2 ± 0.1 
9.1 ± 0.1 
6.6 ± 0.2 
8.0 ± 0.1 
1.24 ± 0.09
1.48 ± 0.23
1.0397 
 (0.0007) 
1.0290 
(0.0007) 
- 
- 
1.22 ± 0.04
1.25 ± 0.09
1.22 ± 0.10
0.94 ± 0.10
- 
- 
- 
- 
1.25 ± 0.07 
1.19 ± 0.10 
1.0325 
(0.0005) 
1.030 
(0.001) 
1.0206 
(0.0003) 
1.15 ± 0.04 
0.76 ± 0.06 
1.29 ± 0.04 
0.77 ± 0.04 
- 
- 
- 
- 
 
Table 3-3. Summary of Isotope Effects for 6PGDH Wild Type and Mutant 
Enzymesa at the 6-Phosphate Site. aValues are ± S.E. 
bFrom Hwang, et al Biochemistry 1998. 
cValues in parenthesis are standard errors for the 13C-kinetic isotope 
effects. 
dNot determined as a result of the deuterium isotope effect near 1. 
eFrom Li and Cook (19). 
fpKa from the V pH profile. 
gpKa from the (V/ K) pH profile. 
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using variable concentrations of 6PG (15-500 µM) and NADP (1-1000 µM) 
dependent on the mutant enzymes.  Data are summarized in Table 3-2. 
KNADP increased for all but T262 mutation, which showed no change compared 
to that of wild type enzyme.  The increase in KNADP for Y191A and K260A is about 
3-fold, while more than an order of magnitude increase is observed for R287A and 
R446A mutant enzymes.  Data suggest that changes in the 6PG binding site 
somehow affect the binding of NADP, i.e., there is a linkage between the two sites.  
In comparison, the value of V/K6PGEt for the R287A and R446A mutant enzymes is 
decreased 104-105 fold, and V/Et is decreased by at least two orders of magnitudes 
with respect to the wild type enzyme. Data indicate that elimination of either of the 
arginine residues dramatically impairs enzyme activity.  On the other hand, V/K6PGEt 
is decreased 30- and 120-fold, respectively, compared to the wild type enzyme, for 
Y191A and K260A mutant enzymes.  Changes in V/Et are smaller with no change in 
the case of Y191A, and a 20-fold change in the case of K260A.  The T262A mutant 
enzyme exhibits a 3-fold change in V/Et and V/K6PGEt, reflecting the 3-fold change in 
the former. 
3.3.3 Kinetic Primary Deuterium Isotope Effects. 
The kinetic deuterium isotope effects on V and V/K6PG were measured at 
saturating NADP (40 Km) (Table 3-3).  The isotope effects on both kinetic 
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parameters are small in all cases, and within error equal to one another, consistent 
with the proposed rapid equilibrium random kinetic mechanism (1).  Isotope effects 
on R287A and R446A were not measured because of the very low activity. 
3.3.4 Solvent Deuterium Kinetic Isotope Effects. 
The solvent deuterium kinetic isotope effects on V and V/K6PG were measured at 
saturating NADP (40 Km), comparing the rates in H2O and D2O (Table 3-3).  Equal 
isotope effects on the two parameters were obtained for the wild type enzyme, Y191A 
and K260A mutations, while for the T262A mutant enzyme D2O(V/K) < D2OV .  For 
all three mutant enzymes, the isotope effects are smaller than those observed for the 
wild type protein.  Multiple primary deuterium / solvent deuterium isotope effects 
were measured for K260A and T262A mutant enzymes at saturating level NADP (40 
Km) (Table 3-3).  For the K260A mutant enzyme DVD2O, within error, is equal to DV, 
while D(V/K)D2O is slightly smaller than D(V/K).  In the case of T262A mutation, 
DVD2O is within error equal to DV, and an inverse value of D(V/K)D2O is obtained. 
3.3.5 13C-Kinetic Isotope effects. 
Data for 13C-kinetic isotope effects obtained with 3-h-6PG and 3-d-6PG are 
shown in Table 3.  For all of the mutant enzymes, the value of 13(V/K6PG)H minus 1 
is at least an order of magnitude higher than that of the wild type enzyme.  
Deuteration of 6PG decreases the observed 13C-kinetic isotope effects for the wild 
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type enzyme as well as that for K260A and T262A, and in all cases the equality for a 
stepwise mechanism with oxidation preceding decarboxylation is satisfied within 
error (13).  13C-kinetic isotope effects were also measured in H2O and D2O to 
determine the multiple solvent deuterium/13C isotope effects, as summarized in Table 
3-3.  Note that there is a decrease in the 13C-kinetic isotope effects when measured 
in D2O. 
3.3.6 pH Dependence of Kinetic Parameters. 
The pH dependence of the kinetic parameters of the mutant enzyme Y191A was 
measured by varying 6PG at saturating level of NADP (40 Km).  Bell shaped pH-rate 
profiles with limiting slopes of 1 and -1 was obtained for V/K6PG and V.  The pKa 
values are summarized in Table 3-3.  The pH-rate profiles for the Y191A mutant 
enzyme is shown in Figure 3-3. 
 
3.4  Discussion. 
 
The main aim of this research was to determine the importance of residues Y191, 
K260, T262, R287 and R446, which interact with the 6-phosphate of 6PG, and their 
role in providing binding energy and proper orientation of the substrate.  On the 
basis of the crystal structure of the E:6PG binary complex, interactions between each 
of the five residues listed and the 6-phosphate of 6PG is suggested.  A multiple 
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sequence alignment of 6PGDHs from a variety of species from bacteria to man 
indicates a complete conservation of all of the residues considered (Figure 3-1).  
Site-directed mutagenesis was used to change Y191, K260, T262, R287 and R446 to 
alanine one at a time to eliminate the interaction between each of the residues and the 
6-phosphate of 6PG.  Steady-state kinetic parameters and isotope effects were 
measured to determine the effect of the substitutions on the ability of 6PGDH to use 
6PG as a substrate. 
Theory for interpretation of kinetic parameters and isotope effects in the 6PGDH 
reaction has been developed previously and equations are reproduced here for aid in 
data interpretation (5, 10).  The oxidative decarboxylation reaction catalyzed by 
6PGDH is stepwise with oxidation preceding decarboxylation as suggested by 
multiple deuterium/13C kinetic isotope effect studies (10).  Multiple solvent 
deuterium kinetic isotope effect and proton inventory studies indicate the presence of 
an isomerization of the enzyme complex prior to hydride transfer and decarboxylation 
(17).  The kinetic mechanism of 6PGDH at saturating NADP can be written: 
 
EAB
EA
EB
E'AB E'XR E'QR
k3B
k4
k3'A
k4'
k5
k6
k7
k8
k9 [7]
 
where A, B, X, Q, and R represent NADP, 6PG, 3-keto-6PG, ribulose 5-phosphate, 
 82
and NADPH, respectively.  The rate constants k3 and k4 are for binding and 
dissociation of 6PG and k3’ and k4’ are for binding and dissociation of NADP, k5 and 
k6 are for an isomerization of E:NADP:6PG complex, k7 and k8 are for forward and 
reverse hydride transfer, and k9 is the rate constant for decarboxylation of the 3-keto 
intermediate and release of CO2.  The deuterium sensitive step, hydride transfer, 
may exhibit an isotope effect upon deuteration of 6PG at the 3-poisition, depicted by 
Dk7 and Dk8, which can be related by the equilibrium isotope effect, DKeq = Dk7/Dk8.  
The 13C-kinetic sensitive step, k9, may exhibit a primary isotope effect, 13k9. 
Given the rapid equilibrium nature of the mechanism, central complex 
interconversion is rate-limiting (steps included from EAB to E’QR, and thus k4,k4' > 
k5, while k11, k13 > k7.  Finally, since the kinetic isotope effects on V and V/K are 
equal to one another for the wild type and each of the mutant enzymes, k6 = (1 + 
k6/k5)/(1/k5 + 1/k9). 
It is possible that the kinetic mechanism of the enzyme changed upon making the 
mutations discussed above.  However, the kinetic mechanism is equilibrium random 
for the wt enzyme (1, 2), and in all of the mutant enzymes with the exception of the 
Y191A mutant enzyme V is decreased.  The only real possibility for a change in 
kinetic mechanism for the remaining mutant enzymes is to an equilibrium ordered 
addition of reactants, and this would have been observed when initial velocity 
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patterns were performed (the Km for one of the reactants would be zero).  In the case 
of the Y191A mutant enzyme, the V/K values for both reactants decrease, and this 
would be difficult to rationalize for other than an equilibrium mechanism. 
On the basis of the above, the following expressions have been developed. 
 
V =
k7
1+ k6
k5
1+
k7
1
k5
+ 1
k9
 
  
 
  
1+ k6
k5
+ k8
k9
 [8] 
V
K6 PG
=
k3k5k7
k4k6
1+ k7
k6
+ k8
k9
 [9] 
DV =
Dk7 +
k7
1
k5
+ 1
k9
 
  
 
  
1+ k6
k5
+ DKeq( ) k8k9
 
  
 
  
1+
k7
1
k5
+ 1
k9
 
  
 
  
1+ k6
k5
+ k8
k9
 [10] 
D
V
K6 PG
 
  
 
  =
Dk7 + k7k6
+ DKeq( ) k8k9
 
  
 
  
1+ k7
k6
+ k8
k9
 [11] 
13
V
K6 PG
 
  
 
  H
=
13k9 + k9 / k8( ) 1+ k7 / k6( )
1+ k9 / k8( ) 1+ k7 / k6( )                                   [12] 
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13
V
K6 PG
 
  
 
  D
=
13k9 + Dk7k9 / k8 DKeq( )1+ k7 / k6 Dk7( )
1+ Dk7k9 / k8 DKeq( )1+ k7 / k6 Dk7( )                      [13] 
Since K6PG is the ratio of V and V/K6PG, and taking into account k6 = (1 + 
k6/k5)/(1/k5 + 1/k9) 
 
K6 PG = k4k3
 
  
 
  
k6
k5 + k6
 
  
 
   [14] 
 
where k4/k3 is the Kd of 6PG for the E:NADP:6PG complex and k6/(k5 + k6) corrects 
for the distribution of the central complexes between E:NADP:6PG and 
E’:NADP:6PG.  Therefore, K6PG is the equilibrium constant for dissociation of 6PG 
from E:NADP:6PG and E’:NADP:6PG.  Using the above rate equations, we discuss 
the results for each of the mutant enzyme. 
The key to interpretation of the data obtained for the mutant enzymes lies in the 
change in K6PG, D(V/K6PG), and 13(V/K6PG).  The increase in K6PG and KNADP likely 
results from an increase in the net off-rates for 6PG and NADP from E’:NADP:6PG, 
k4k6/(k5 + k6) (k4'k6/(k5 + k6) in the case of NADP), suggesting an increase in k4, k6, 
or both.  Since the Km values of both substrates are affected, it is likely to be both.  
The conformational change that precedes the catalytic steps represented by k5 and k6 
in mechanism 7, requires both reactants bound as suggested by a superposition of the 
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E:Nbr8ADP and E:6PG complexes (6), which gives a hydride transfer distance of 5.3 
Å, which is much too long.  Therefore a conformational change that brings the two 
substrates close together is required. 
3.4.1 The R287A and R446A Mutant Enzymes. 
As shown in Table 2, K6PG increases by about 800-fold and 120-fold for R287A 
and R446A, respectively, compared to the value of the wild type enzyme.  In 
addition, V/Et decreases about 600- and 300-fold respectively, resulting in a V/K6PGEt 
more than 10,000 times lower than that of the wild type protein.  Because of the very 
low activity, no further characterization was carried out on the two mutant enzymes.  
On the basis of the measured kinetic parameters, the affinity of the mutant enzymes 
for their substrate 6PG decreases substantially (∆∆Go 3.95 and 2.81 kcal/mol for 
R287A and R446A, respectively), and the ability of the mutant enzymes to catalyze 
reaction is severely impaired, as a result of eliminating hydrogen-bonding and ionic 
interactions contributed by the arginine residues.  Given the expression for K6PG, eq. 
14, the net rate constant for release of 6PG is increased.  Since there is also an 
observed greater than10-fold increase in KNADP it is likely, as suggested above, that 
part of the increase results from a change in the equilibrium position of the 
conformational change that precedes the hydride transfer step to favor EAB, 
mechanism 7. 
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3.4.2 The Y191A Mutant Enzyme. 
Data for replacement of Y191 with A are interesting in that V/Et is increased by 
about 20% (1.17 ± 0.06, Table 2).  One would thus not expect much change in the 
isotope effects.  This is not the case, and significant changes in the magnitude of the 
isotope effects are observed.  The V and V/K6PG pH-rate profiles for the Y191A 
mutant enzyme exhibits pK values that are closer together than those observed for the 
wt enzyme, Table 3-3.  (The phenomenon is easier to see and explain using the V/K 
profiles.  The same phenomenon is apparent for the V pH-rate profiles, but one of 
the pK values is too high to be observed in the case of the wt enzyme.)  The V/K6PG 
pH-rate profiles reflect reverse protonation states between the K183 general base and 
the E190 general acid (4), and thus the amount of active enzyme can be estimated 
from the antilog of the difference between the acid and base pK values.  In the case 
of the wt enzyme, the fraction of active enzyme is 0.5%, while in the case of the 
Y191A enzyme the value is 4%, representing a 8-fold increase, i.e. a value of 70 s-1 
would be expected compared to the value of the wt enzyme, Table 3-2.  The 
observed value of V/Et for the Y191A mutant enzyme, therefore, reflects an 8-fold 
decrease in the actual value of V/Et.  The tyrosine donates a single hydrogen bond to 
the phosphate, Figure 3-3.  Changing Y to A, results in a 40-fold decrease in affinity. 
In the wt enzyme, the 13C kinetic isotope effect is 1.0028, while when it is  
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Figure 3-3. pH Dependence of Kinetic Parameters for the Y191A Mutant of 
6-PGDH.  Data were obtained for V (A) and V/K6PG (B). The points 
shown are the experimentally determined values and the curves are from 
a fit of the data using eq.4. 
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measured in D2O, the number decreases to 1, indicating that under D2O condition, the 
decarboxylation step is not rate limiting at all.  Given the solvent deuterium isotope  
effect about 2 on both V and V/K6PG and the primary deuterium isotope effect about 
1.9 on V and V/K6PG, it is suggested that in the wt enzyme rate-limitation arises 
mostly from the isomerization and the hydride transfer step.  In the Y191A mutant 
enzyme, the value of 13(V/K6PG) has increased to 1.0269, concomitant with a decrease 
in DV and D(V/K6PG) to a small finite value.  Data suggest a decrease in the rate of 
the decarboxylation step relative to hydride transfer.  The solvent deuterium isotope 
effect is finite, but slightly lower in value compared to the wt enzyme, and the 
multiple 13C/solvent deuterium effect indicates some of this is on a step other than 
decarboxylation.  Since the effect is normal and not inverse, the hydride transfer step 
likely contributes part of the effect (see T262A below, 17).  Therefore, in the Y191A 
mutant enzyme, decarboxylation is predominantly rate-limiting. Isomerization and 
hydride transfer also contribute to rate-limitation.  In addition to the large increase in 
K6PG, the mutant enzyme exhibits a 3-fold increase in KNADP suggesting a change in 
the rate of the conformational change that precedes hydride transfer.  Data further 
suggest that occupancy of the 6-phosphate-binding site is needed to generate the 
enzyme's optimum catalytic conformation. 
3.4.3 The T262A Mutant Enzyme. 
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Only in the case of the T262A mutant enzyme is there no observed change in K6PG, 
suggesting no significant binding energy is provided by this side chain.  This is not 
surprising, given the 3.7 Å distance from the T side chain to the 6-phosphate (6) 
(Figure 3-2).  However, a 3-fold decrease in V/Et is observed and the isotope effects 
differ significantly from those obtained for the wild type enzyme.  The large value of 
13(V/K6PG), 1.0325, indicates the decarboxylation step has become predominantly 
rate-limiting overall, and the primary kinetic deuterium isotope effects is close to the 
value of the equilibrium deuterium isotope effect of 1.18 on the hydride transfer step 
(18).  The multiple deuterium/13C isotope effect is decreased slightly consistent with 
the small deuterium isotope effect.  The increase in the 13C isotope effect to 1.0325 
(the effect for wt is 1.0028) can be used to estimate the partition ratio for the 
3-keto-6PG intermediate in the case of the wt enzyme.  Substituting 1.0325 for 13k9 
in eq. 11 and 1.0028 for 13(V/K6PG), gives a value of 10.6 for k9/k8.  Thus, in order to 
see the increased value of 13(V/K6PG) the partition ratio for the 3-keto-6PG 
intermediate must decrease by a factor of 10.  The change in partition ratio is much 
greater than the observed decrease in V/Et (3-fold), and thus it is likely that the 
fraction of enzyme that is catalytically competent has increased in the case of the 
mutant enzyme as suggested above for the Y191A mutant enzyme, or that a step 
within the catalytic pathway has increased in rate (this would most likely be k7 since 
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it is included in both V and V/K). 
An inverse solvent deuterium kinetic isotope effect is observed on V/K, and this 
likely reflects a medium effect on the conformation change that precedes hydride 
transfer (17).  Deuteration of the substrate has no significant effect on the inverse 
solvent effect on V/K; this is not surprising given the small value of D(V/K).  Of 
interest, the solvent deuterium isotope effect on V is normal, and this may be 
indicative of some rate-limitation by tautomerization of the enediol of ribulose 
5-phosphate, but this will require additional study. 
3.4.4 The K260A Mutant Enzyme. 
Lysine 260 donates a hydrogen bond from its backbone NH to the 6-phosphate, 
and also provides van der Waals interactions via its side chain and the backbone of 
6PG.  Changing K260 to alanine gives a greater than 5-fold decrease in the affinity 
of 6PGDH for 6PG.  This change in binding energy likely reflects the van der Waals 
interactions since the backbone NH will still be present (although it may not be in 
position to donate a hydrogen bond).  As stated above, the increase in both KNADP 
and K6PG suggest a decrease in the rate of the conformational change to set the active 
site up for catalysis.  Data further suggest either a requirement for occupancy of the 
6-phosphate site or proper binding of 6PG to generate an optimum catalytic 
conformation, that is, utilization of the binding energy of 6PG to catalyze the 
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reaction. 
The 20-fold decrease in V likely results from a decrease in the rate of the 
decarboxylation step, k9, consistent with the estimated 13-fold decrease in k9/k8, 
calculated as above for the T262A mutant enzyme.  The largest value of 13(V/K6PG) 
is observed for this mutant enzyme.  The decreased value of the deuterium isotope 
effects is also consistent with the increased rate-limitation of the decarboxylation step.  
However, the values of DV and D(V/K6PG) are greater than DKeq suggesting a small 
contribution to rate-limitation by the hydride transfer step.  In agreement, the values 
of D2OV and D2O(V/K6PG) are finite and normal, suggesting a contribution from either 
hydride transfer, decarboxylation, or both (17).  The observed decrease in the 
solvent isotope effect to a value of 1 is consistent with a decrease in the observed 
solvent isotope effects on decarboxylation, as a result of the inverse effect on the 
conformational change preceding hydride transfer.  The finite value of the effect on 
V may again suggest a contribution from the tautomerization step.  Data are also 
consistent with the structural data of Adams (6), which show that the alkyl side chain 
of K260 rests against the backbone of 6PG.  The effect of removing the lysine side 
chain could introduce a significant positional change of the bound substrate, resulting 
in a poorly orientated 6PG, a subsequent decrease in the rate of the conformational 
change to establish the catalytic conformation and decrease the rate of 
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decarboxylation. 
3.4.5 Evidence for Interaction Between the Two Substrates Binding Sites. 
A summation of the ∆∆Go values estimated from all of the mutations greatly 
exceeds the total binding energy of 6PG.  It is apparent that the 6-phosphate of 6PG 
is a very important binding determinant for the substrate.  Occupancy of the 
6-phosphate binding site appears to be critical for proper positioning of the substrate 
for the subsequent catalytic steps, most importantly decarboxylation (see above).  
Another way of putting this is that occupancy of the 6-phosphate binding site is 
important for the reaction, likely to induce the conformational change in enzyme 
preceding catalysis.  In agreement with this suggestion, there is an increase in KNADP 
for all the mutant enzymes, with the exception of T262A, ranging from 3-fold to 
15-fold.  According to the crystal structures of wild type protein with ligands bound, 
the coenzyme binding pocket is separated from the 6PG binding site (6).  Since all 
of the mutations reside in the 6PG-binding site and no significant change in the 
overall structure of the mutant enzymes was detected, it is suggested that the two sites 
are linked, likely via the induced conformational change.  To this point, there is no 
direct evidence to suggest where and how the two sites are linked.  In addition, a 
ternary complex of 6PGDH with both substrates bound is not available.  An overlay 
of the two binary complexes (E: Nbr8ADP and E:6PG) (5) can be used as a starting  
 93
 
 
 
 
 
Figure 3-4. Possible Linkage Between the Cofactor and Substrate Binding Sites. In 
the figure C is green, N is blue, O is red, and P is magenta.  The 
structure of E:6PG complex is shown in green and the structure of E: 
Nbr8ADP complex is shown yellow.  The highlighted region (red) 
represents the proposed linkage that connects the two sites.  The figure 
was created using PyMOL from DeLano Scientific LLC 
(www.pymol.org).  Accession numbers in the PDB are 1PGN and 
1PGP for the E:Nbr8ADP and E:6PG structures, respectively. 
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point for identification of a proposed pathway that connects the sites, as shown in 
Figure 3-4.  The green colored structure is from the E:6PG binary complex and the 
yellow colored structure is the E: Nbr8ADP complex.  The highlighted region (red) 
including loops (residue 8-12, 31-34, 73-78, 100-103, 128-131 and 258-261) and a 
helix (residue 79-83) on both sides of the dinucleotide provides a possible linkage.  
Further experiments including site-directed mutagenesis in the proposed region and 
structure analysis will help to test the putative linkage between sites. 
However, one of the things we anticipated is that the bound substrate would 
change in its position within its binding site in the mutant enzymes compared to the 
wild type enzyme.  This is likely what has occurred in most cases given the change 
in the relative rates of hydride transfer and decarboxylation.  Care must be taken in 
interpreting data for mutant enzymes when alanine is substituted for a residue with a 
larger volume side chain, since the position of the bound reactant can change when 
large changes are made by site-directed mutagenesis.  Isotope effects and multiple 
isotope effects, when they can be measured, greatly facilitate the interpretation of the 
data. 
3.4.6 Note Added in Proof. 
Consistent with the suggestion that decarboxylation is rate-limiting for the mutant 
enzymes, we have recently measured pre-steady state time courses following the 
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appearance of NADPH, mixing enzyme with both substrates.  A rapid burst is 
observed followed by a slow steady state rate that is equivalent to V/Et.  The burst 
amplitude is equal to Et in the case of the K260A and T262A mutant enzymes.  
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Chapter 4 
Roles of S128, H186 and N187 
 
4.1 Introduction 
6-Phosphogluconate dehydrogenase (6PGDH1; EC 1.1.1.44) catalyzes the 
reversible oxidative decarboxylation of 6-phosphogluconate (6PG), giving 
ribulose-5-phosphate (Ru5P) and CO2 with the concomitant production of NADPH.  
The kinetic mechanism is rapid equilibrium random on the basis of a complete kinetic 
characterization of the enzymes from sheep liver and Candida utilis (1, 2).  The pH 
dependence of kinetic parameters indicates a general acid-general base chemical 
mechanism (1, 2), and site-directed mutagenesis studies suggest that K183 and E190 
are the general base and the general acid, respectively (3, 4).  In this mechanism, the 
general base (K183) is required to accept a proton from the 3-hydroxyl group of 6PG 
concomitant with hydride transfer from C-3 of 6PG to the coenzyme.  The resulting 
3-keto-6-phosphogluconate intermediate is decarboxylated to produce the enediol of 
Ru5P with the general base used to protonate the carboxyl oxygen.  A general acid 
(E190) is needed to facilitate the tautomerization of the enediol of Ru5P to the keto 
product (Figure 1-6). 
Previous studies suggest that NADPH play a non-redox role in the 6PGDH 
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catalyzed reaction (5 - 9).  It has been suggested that after hydride transfer, the 
nicotinamide ring of NADPH rotates around the N-glycosidic bond to a position that 
was occupied by the 1-carboxylate of 6PG to facilitate decarboxylation (10).  The 
structures of the E:6PG and E:NADPH binary complexes indicate that residue S128 
and N187 are within hydrogen-bonding distance to the 1-carboxyl group and 
3-hydroxyl group of 6PG, respectively, prior to hydride transfer and are interacting 
with NADPH after hydride transfer.  Histidine 186 interacts with the nicotinamide of 
NADPH in the E:NADPH binary complex, but is within hydrogen-bonding distance 
to S128 and N187 in the E:6PG binary complex (Figures 4-1 and 4-2) (11).  Multiple 
sequence alignment of 6PGDHs from a number of species from bacteria to man 
shows that S128, H186 and N187 are completely conserved (Figure 4-3).  Data 
suggest that the residues may be important in binding of 6PG prior to hydride transfer 
and anchoring the nicotinamide ring of NADPH to facilitate decarboxylation after 
rotation of the nicotinamide ring. 
In this chapter we investigate the role of each of the three residues play along the 
reaction pathway.  Site-directed mutagenesis was used to change S128, H186 and 
N187 to A, one at a time.  Initial velocity, pH and isotope effects studies were 
carried out to characterize the mutant enzymes.  Data are consistent with the roles 
for S128, H186 and N187 in binding of 6PG and NADPH, and in guiding the rotation 
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of the nicotinamide ring after hydride transfer. 
4.2. Material and Methods 
 
4.2.1 Chemicals and Reagents. 
Oligonucleotide primers for mutagenesis and sequencing were from Biosynthesis, 
GibcoBRL and Invitrogen.  The Altered site II in vitro mutagenesis system was 
purchased from Promega.  The Geneclean® II kit was from Bio 101, Inc.  The 
PerfectPrep® Plasmid Mini kit was from Eppendorf.  The DNA molecular ladder 
was from New England Biolabs.  Restriction endonucleases, deoxynucleoside 
triphosphates, and protein molecular mass markers were purchased from Gibco-BRL. 
Acetaldehyde, acetate kinase, ADP-agarose resin, ATP, ampicillin, 
glucose-6-phosphate dehydrogenase (G6PDH), hexokinase, kanamycin, lithium 
potassium acetyl phosphate, the trisodium salt of 6PG, NADP, and pyrophosphate 
were from Sigma-Aldrich, Co.  β–D-(3-deutero)-glucose (98 atom% D) was from 
Omicron Biochemicals, Inc.  Ni-NTA agarose resin was purchased from QIAGEN.  
Glycerol and sulfuric acid were from Fisher-Scientific, Co.  IPTG was from Gold 
Bio Technology (GBT).  Hepes, Bis-Tris, and Ches buffers were from Research 
Organics, Inc.  Deuterium oxide (99 atom% D) was from Cambridge Isotope 
Laboratories, Inc.  All other chemicals were the highest quality available. 
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Figure 4-1. S128, H186 And N187 in the E:6PG binary complex.  In the figure C is 
green, N is blue, O is red, and P is magenta.  The dashed lines represent 
potential hydrogen bonds between the residues of interest and the 
substrate.  The numbers above the dashed lines are the hydrogen bond 
distances in Å.  The figure was created using PyMOL from DeLano 
Scientific LLC (www.pymol.org).  The accession number in the PDB is 
1PGP for the E:6PG structure. 
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Figure 4-2. S128, H186 And N187 in the E:NADPH binary complex.  In the figure 
C is green, N is blue, and O is red.  The dashed lines represent potential 
hydrogen bonds between the residues of interest and the cofactor.  The 
numbers above the dashed lines are the hydrogen bond distances in Å.  
The figure was created using PyMOL from DeLano Scientific LLC 
(www.pymol.org).  The accession number in the PDB is 1PGO for the 
E:NADPH structure. 
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Figure 4-3. Multiple Sequence Alignment of 6-Phosphogluconate Dehydrogenase 
Sequences Around Position S128, H186 and N187. 
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4.2.2 Bacterial Strain and Plasmids. 
The Escherichia coli strain XL1-Blue was used to transform the mutated plasmid 
and M15[pREP4] was the host strain for expression of the mutant proteins.  The 
plasmid pQE-30 was used as both mutagenesis and expression vector. 
4.2.3 Site-Directed Mutagenesis. 
The Altered site II in vitro mutagenesis system from Promega was used to 
perform site-directed mutagenesis.  Single-stranded DNA prepared from 
recombinant plasmid pPGDH.LC5 (12) was used as a template and the synthetic 
oligonucleotide primers are listed in Table 4-1.  Newly synthesized DNA was 
recovered from the recipient strain ES1301 mutS and subsequently transformed into 
JM109. Gene sequencing was performed for every mutation at the Laboratory for 
Genomics and Bioinformatics of the University of Oklahoma Health Science Center 
in Oklahoma City.  The resulting sequence was compared to that of the wild type 
6PGDH using BLAST.  Two synthesized oligonucleotides containing the desired 
restriction sites were constructed (Table 1).  One primer creates a SphI restriction 
site at the start of the gene, and the other one contains a HindIII site at the end of the 
gene.  The two sites were introduced into the gene containing the desired mutation 
using polymerase chain reaction (PCR).  The PCR product was subcloned into the 
pQE30 vector via the corresponding restriction sites.  Successfully mutated plasmids 
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were transformed into M15[pREP14] competent cells, the expression host.  Frozen 
stocks of strains harboring plasmid were stored in LB/ampicillin/kanamycin medium 
containing 15% glycerol at -80 oC. 
4.2.4 Growth and Purification Conditions. 
The bacterial strain containing the mutated plasmid was first grown in 50-200 
mL LB medium, containing 100 µg/mL ampicillin and 25 µg/mL kanamycin at 37 oC, 
overnight in a water-bath shaker.  The next day, this culture was transferred into 2-10 
liters of LB/Amp/Kan medium and was incubated at 25 oC for 8 hours or until the 
A600 reached 0.6.  IPTG was then added to a final concentration of 1 mM to initiate 
expression.  After 16 hours of growth at 25 oC with shaking, the cells were harvested 
by centrifugation at 5,000 g for 30 minutes.  The cell pellet was resuspended in 
4volumes of Buffer A (50 mM triethanolamine, 2 mM β–mercaptoethanol, pH 7.5), 
sonicated on ice for 3 minutes, (pulsing 30 seconds with 30 seconds rest) using a 
MISONIX Sonicator® XL, and centrifuged at 25,000 g for 30 minutes.  The 
supernatant was combined with 2-10 mL of Ni-NTA resin pre-equilibrated with 
Buffer A and stirred at 4 oC for 2 hours.  The mixture was then loaded into a 25 mL 
column, and the column was washed with 5 volumes of Buffer A containing 20 mM 
imidazole.  Elution made use of an imidazole gradient (0.2-0.4 M, dependent on the 
freshness of the resin).  Protein concentrations were measured for all fractions using  
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Table 4-1. Sequence of Oligonucleotide Primers for mutation S128A, H186A and 
N187A. Mutated codons are in bold. 
S128A GGGAGCGGAGTTGCTGGTGGAGAGGA 
H186 GTGAAGATGGTGGCCAACGGCATAGAG 
N187A AAGATGGTGCACGCCGGCATAGAGTAC 
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the method of Bradford (13).  Fractions containing protein were pooled and applied 
to an ADP-agarose affinity column, which takes advantage of the NADP binding site 
in the protein.  Pooled fractions from the Ni-NTA column were applied to the 
ADP-agarose column directly, with a flow rate of 2 mL/min.  The column was then 
washed with 10 volumes of Buffer A and protein was eluted with 150 mM 
pyrophosphate buffer, pH 7.5, containing 1 mM EDTA and 2 mM β–mercaptoethanol.  
Fractions were collected and protein concentration was determined by reading the 
absorbance at 280 nm (ε = 62,160 M-1cm-1 for 6-His tagged 6PGDH).  Fractions 
containing protein were again pooled and concentrated using an Amicon 
ultrafiltration apparatus with a PM-30 semipermeable membrane.  SDS-PAGE was 
performed for wild type and all mutant enzymes to analyze the purity of the protein. 
The wild type and mutant proteins were purified in an identical manner, and all 
enzymes were stored at 4 oC in the same buffer used for elution from the 
ADP-agarose column. 
4.2.5 Synthesis of 3-d-6PG. 
3-deutero-glucose was converted to 3-deutero-glucose 6-phosphate 
enzymatically using hexokinase as described previously (14).  The extent of 
conversion to the product of the reaction was determined by end-point assay using 
glucose-6-phosphate dehydrogenase.  Upon completion of the reaction, the pH of the 
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solution was adjusted to 4.5 to denature the enzymes in the mixture and Amicon 
ultrafiltration was used to remove the enzymes.  The resulting solution was treated 
with acid-washed and heat-activated charcoal, stirred for 1 hour and filtered to 
remove nucleotides and then Dowex 50W-H+ resin was used to remove Mg2+.  The 
solution, containing 3-d-glucose 6-phosphate, was bromine oxidized to yield the final 
product 3-d-6PG, which was purified as described previously (10). 
4.2.6 Initial Velocity Studies. 
Initial velocity studies were performed using a Beckman DU640 UV/Vis 
spectrophotometer.  The appearance of NADPH (ε340 = 6.22 mM-1 cm-1) was 
monitored over time using 1 cm pathlength semi-micro quartz cuvettes.  The 
temperature was maintained at 25 oC using a Beckman Temperature Controller.  
Initial velocity patterns were measured for all mutant and wild type enzymes in 100 
mM Hepes, pH 7.5, using variable concentrations of 6PG and NADP dependent on 
the mutant enzyme. 
The Ki for NADPH as an inhibitor competitive vs NADP was measured with 
6PG equal to its Km (E:NADP) and at saturating (20Km) concentration 
(E:NADP:6PG). Data were obtained for the wild-type and mutant enzymes as above 
at pH 7.5. 
4.2.7 pH Studies. 
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Initial velocity data were measured as a function of pH under conditions in 
which 6PG was varied while NADP was fixed at saturation (40 Km).  The pH was 
maintained using the following buffers at 100 mM concentrations: Bis-Tris, 5-6.5; 
Hepes, 6.5-8.5; Ches, 8.5-9.5.  Sufficient overlap was obtained upon changing 
buffers to eliminate inhibition buffer effects.  The pH was determined before and 
after the initial velocity measurements. 
4.2.8 Primary Deuterium Kinetic Isotope Effects. 
The concentrations of 3-h-6PG and 3-d-6PG were determined enzymatically in 
triplicate by end-point assay using wild type 6PGDH.  The concentrations from three 
determinations were in agreement within 2%.  Primary deuterium isotope effects 
with 3-d-6PG were obtained for all the mutant enzymes as well as for the wild type 
enzyme by direct comparison of initial velocities (15).  DV and D(V/KNADP) were 
obtained in triplicate by varying NADP at saturating levels of either 3-h-6PG or 
3-d-6PG (20 Km), while DV and D(V/K6PG) were measured in triplicate varying 
3-h-6PG or 3-d-6PG at saturating concentrations of NADP (40 Km). 
4.2.9 Solvent Deuterium Kinetic Isotope Effects. 
Initial velocities for the wild type and mutant enzymes were measured in both 
H2O and D2O solutions.  Substrates (NADP and 3-h-6PG) and buffers used in D2O 
solutions were first dissolved in small volume of D2O and lyophilized overnight to 
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remove exchangeable protons.  The lyophilized powders were then dissolved in D2O 
to give the desired concentrations and pD was adjusted using either DCl or NaOD.  
Primary solvent deuterium isotope effects were obtained by direct comparison of 
initial velocities in the pH/pD independent region. 
4.2.10 13C-Kinetic Isotope Effect. 
These effects were measured using the natural abundance of 13C at the C-1 
position of 6PG (16).  Both high conversion (100% reaction, which represents 
12C/13C in substrate) and low conversion samples were used to measure the 12C/13C 
isotope ratios in the CO2 produced from the reaction of 3-h-6PG or 3-d-6PG.  From 
these ratios, the 13C-kinetic isotope effect was calculated (17). 
For high conversion samples, in 40 mL of H2O or D2O, the reaction mixtures 
contained 2 mM 3-h-6PG or 3-d-6PG, 0.5 mM NADP and 10 mM oxidized 
glutathione.  The low conversion reactions contain 6.5 mM 3-h-6PG or 3-d-6PG for 
the enzymes that have a K6PG close to that of the wild type 6PGDH (28 µM), or 15 
mM, if K6PG was higher.  The NADP concentration was 0.25 mM for enzymes with 
a KNADP about 2 µM or 1mM if KNADP was higher (greater than 20 µM). All low 
conversion samples contained 5 mM oxidized glutathione in a final volume of 40 mL.  
The pH(D) of the reaction solutions was titrated to 7.6, followed by sparging with 
CO2-free nitrogen overnight.  Before starting the reactions, aliquots were withdrawn 
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to determine the initial concentrations of 6PG by end-point assay in triplicate.  Then 
the reactions were initiated by the addition of 2 units of 6PGDH and 100 units of 
glutathione reductase to recycle NADP for both high and low conversion samples. 
The high conversion samples were allowed to proceed for more than 16 hours 
and end-point assays were used to confirm the completion of the reaction.  For the 
low conversion samples, extents of reaction were monitored by end-point, assaying 
the remaining 6PG.  Reactions were quenched when 50 µmole of CO2 were 
produced.  For both high and low conversion samples, 0.2 mL of concentrated 
sulfuric acid was added to quench the reactions and the generated CO2 was isolated 
by vacuum distillation (18).  Aliquots of the samples were withdrawn after the CO2 
isolation and incubated at pH 8 overnight.  The next day, end-point assays were 
performed in triplicate to determine the exact extent of the low conversion reactions.  
Isotopic composition of the CO2 was measured on a Finnigan Delta E isotope-ratio 
mass spectrometer in the laboratory of Dr. Michael Engel, Department of Geophysics, 
University of Oklahoma.  All ratios were corrected for 17O according to Craig (19). 
4.2.11 Nomenclature. 
Isotope effects are expressed using the nomenclature developed by Northrop (20) 
and Cook and Cleland (21).  Deuterium, 13C, and solvent deuterium kinetic isotope 
effects are written with a leading superscript D, 13, or D2O, e.g. a primary deuterium 
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isotope effect on V/K is written D(V/K).  Multiple isotope effects are written with a 
leading superscript to depict the isotope varied, and a following subscript to depict the 
fixed isotope, e.g. a solvent deuterium isotope effect measured with deuterated 6PG 
would be written D2O(V/K)D. 
4.2.12 Data Processing. 
Double reciprocal plots were used to analyze the data and all plots and replots 
were linear.  Data were fitted using the appropriate rate equations and programs 
developed by Cleland (22).  Data for substrate saturation curves obtained at a fixed 
concentration of the second substrate were fitted using eq. 1.  Initial velocity patterns 
were fitted using eq. 2.  Deuterium kinetic isotope effect data in H2O and D2O were 
fitted using eq. 3.  In eqs. 1 and 2, v is the initial velocity, V is the maximum velocity, 
A and B are reactant concentrations, Ka and Kb are the Michaelis constants for NADP 
and 6PG, respectively, and Kia is the dissociation constant for NADP.  In eq. 3, Fi is 
the fraction of deuterium label in the substrate or solvent, and EV and EV/K are the 
isotope effects minus 1 on V and V/K. 
 
v = VA
Ka + A
                 [1] 
v = VAB
KiaKb + KaB+ Kb A+ AB
             [2] 
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v = VA
Ka 1+ FiEV/K( )+ A 1+ FiEV( )             [3] 
 
The pH dependence of V and V/K were fitted using eq. 4, in which y is V or V/K, 
C is the pH independent value of y, H is the hydrogen ion concentration, and K1 and 
K2 are the acid dissociation constants for enzyme or substrate groups important in a 
given protonation state for optimal binding and/or catalysis. 
 
log y = log C
1+ H /K 1+ K2 / H
 
  
 
              [4] 
 
Calculation of 13C-kinetic isotope effects was performed according to eq. 5, where 
f is the fraction of completion of the reaction, Rp and R∞ are the 12C/13C isotopic ratios 
for CO2 at partial and complete conversion, respectively.  Isotope ratios, given as 
δ13C, were calculated from eq. 6, where Rsmp and Rstd are 12C/13C isotopic ratios for 
sample and standard, respectively.  The standard for CO2 was calibrated from Pee 
Dee Belemnite with a 12C/13C of 0.0112372 (19). 
   
13 V /K( )= log 1− f( )
log 1− f Rp / R∞[ ]( ) [5] 
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δ 13C( )= RsmpRstd − 1
 
  
 
  x 10
3
 [6] 
 
4.3 Results 
 
4.3.1 Spectral Properties of Mutant Enzymes. 
Far UV CD spectra were recorded for all mutant and wild type enzymes, and all 
were identical after adjusting for protein concentration (data now shown).  As a 
result, there are no major changes in the overall structure of the enzyme resulting 
from the mutation, and changes are restricted to the local area within the active site. 
4.3.2 Kinetic Parameters of the Mutant Enzymes. 
Initial velocity patterns were obtained by measuring the initial rate at pH 7.5 
using variable concentrations of 6PG and NADP dependent on the mutant enzyme.  
Data are summarized in Table 4-2. 
All three mutant enzymes exhibit a decreased V/Et, ranging from 7- to 67-fold.  
No significant change was observed in KNADP of the S128A and H186A mutant 
enzymes, while the KNADP of the N187A mutant enzyme increases about 6-fold with 
respect to the value of the wild-type enzyme.  Data suggest that changes in the 6PG 
binding site somehow affect the binding of NADP, i.e., there is a linkage between the 
two sites.  In contrast, K6PG increases 3- and 19-fold for the S128A and N187A 
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mutant enzymes, respectively, and K6PG decreases about 2-fold in the H186A 
mutation, resulting in a decrease in V/K6PGEt 3- to 1300-fold. 
4.3.3 Inhibition and Dissociation Constants for NADPH. 
The inhibition constants for NADPH vs NADP, obtained at saturating 6PG for 
the mutant enzymes, are given in Table 4-3.  In addition, the Ki for NADPH as a 
competitive inhibitor vs NADP at Km level of 6PG was measured.  Data are 
summarized in Table 4-3.  In all cases, Ki for NADPH of all the mutant enzymes is 
greater than the value estimated for the wild type enzyme. 
4.3.4 Kinetic Primary Deuterium Isotope Effects. 
The kinetic isotope effects on V and V/K6PG were measured at saturating NADP 
(40 Km) (Table 4-4). The isotope effects are smaller than the values obtained with the 
wild type enzyme in all cases, and within error equal to each other, consistent with the 
proposed rapid equilibrium random kinetic mechanism (1). 
4.3.5 Solvent Deuterium Kinetic Isotope Effects. 
The solvent deuterium kinetic isotope effects on V and V/K6PG were measured at 
saturating NADP (40 Km), comparing the rates in H2O and D2O (Table 4-4).  For all 
three mutant enzymes, the isotope effects are smaller than those observed for the wild 
type protein, with the exception of D2O(V/K) of S128A.  An inverse solvent kinetic 
deuterium isotope effect is obtained for the H186A and N187A mutant enzymes. 
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 wt S128A H186A N187A 
V/Et (sec-1) 
Fold decrease 
KNADP (µM) 
Fold increase 
K6PG (µM) 
Fold increase 
V/K6PGEt (M-1s-1) 
Fold decrease 
∆Go (kcal mole-1)b 
∆∆Go (kcal mole-1)b 
9.4 ± 0.4
- 
5 ± 1 
 
28 ± 4 
 
3.4 x 105 
 
-6.2 
 
0.49 ± 0.05 
19 
5.4 ± 0.1 
- 
95 ± 8 
3 
5.2 x 103 
65 
-5.5 
0.7 
1.40 ± 0.04 
7 
2.0 ± 0.1 
- 
12.1 ± 0.1 
- 
1.2 x 105 
3 
-6.7 
- 
0.14 ± 0.04 
67 
29.8 ± 0.5 
6 
530 ± 1 
19 
260 
1.3 x 103 
-4.5 
1.7 
 
Table 4-2. Summary of the Kinetic Parameters for 6PGDH Wild Type and the 
S128A , H186A and N187A mutant enzymes. 
aValues are ± S.E. 
bValues are calculated from K6PG, using ∆Go = -RTlnK6PG. 
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 wtd S128A H186A N187A 
6PG (s)b 8 ± 2 19 ± 7.5 27 ± 5.7 9.3 ± 1.3 
Fold increase - 2 3 - 
6PG(ns)c 1.8 ± 0.3 12 ± 0.7 9.5 ± 1.6 2.8 ± 0.1 
Fold increase  6 5 1.6 
 
Table 4-3. Summary of Ki for NADPH for the Wild Type and the S128A , H186A 
and N187A mutant enzymes. 
   aValues are ± S.E.  
bs, saturating (20Km) 
cns, nonsaturating (Km) 
dFrom Price and Cook, Arch. Biochem. Biophys. 1996 
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 wt S128A H186A N187A 
DV 
D(V/K6PG) 
13(V/K6PG)H 
 
13(V/K6PG)D 
 
D2OVH 
D2O(V/K6PG)H 
13(V/K6PG)D2O 
 
pKa (V)f 
f 
pKa (V/K)g 
g 
1.9 ± 0.1b 
1.9 ± 0.1b 
1.0028 
(0.0007)c 
1.0017 
(0.0005) 
2.10 ± 0.05
1.9 ± 0.2 
1 
 
6.40 ± 0.04e
- 
6.2 ± 0.2 e
8.5 ± 0.1 e
1.2 ± 0.1 
1.2 ± 0.2 
1.0152 
(0.0005) 
N.D.d 
 
1.5 ± 0.1 
0.8 ± 0.2 
1.0096 
(0.0007) 
5.5 ± 0.1 
9.6 ± 0.1 
6.3 ± 0.1 
7.6 ± 0.1 
1.5 ± 0.1 
1.4 ± 0.1 
1.0088 
(0.0005) 
1.0083 
(0.001) 
1.03 ± 0.07 
0.72 ± 0.09 
1.0040 
(0.0003) 
6.1 ± 0.1 
- 
6.3 ± 0.1 
8.4 ± 0.1 
1.10 ± 0.04 
1.02 ± 0.02 
1.0209 
(0.0011) 
N.D.d 
 
1.4 ± 0.2 
0.7 ± 0.3 
1.0096 
(0.0008) 
6.6 ± 0.1 
- 
6.7 ± 0.2 
8.9 ± 0.1 
Table 4-4. Summary of Isotope Effects and pKa Values for the Wild Type and the 
S128A , H186A and N187A mutant enzymes. 
aValues are ± S.E. bFrom Hwang, et al Biochemistry 1998 (14). 
cValues in parenthesis are standard errors for the 13C-kinetic isotope 
effects. dNot determined as a result of the deuterium isotope effect near 1. 
eFrom Li and Cook (19). fpKa from the V pH profile. gpKa from the 
(V/K) pH profile. 
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4.3.6 13C-Kinetic Isotope effects. 
Data for 13C-kinetic isotope effects obtained with 3-h-6PG and 3-d-6PG are 
shown in Table 4-4.  For all of the mutant enzymes, the value of 13(V/K6PG)H minus 1 
is increased at least 3-fold greater compared to the value of the wild type enzyme, 
indicating that the decarboxylation step has become slower for the mutant enzymes 
than it is in the wild type enzyme.  13C-kinetic isotope effects were also measured in 
H2O and D2O to determine the multiple solvent deuterium/13C isotope effects, as 
summarized in Table 4.  Note that there is a decrease in the 13C-kinetic isotope 
effects when measured in D2O. 
4.3.7 pH Dependence of Kinetic Parameters. 
The pH dependence of the kinetic parameters was measured for all of the mutant 
enzyme by varying 6PG at saturating level of NADP (40 Km).  Bell shaped pH-rate 
profiles with limiting slopes of 1 and -1 were obtained for V/K6PG and there is only 
one pK in the V profile, with the exception of the S128A mutant enzyme.  The pKa 
values are summarized in Table 4-4.  The pH-rate profiles for the S128A mutant 
enzyme is shown in Figure 4-4. 
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Figure 4-4. pH Dependence of Kinetic Parameters for the S128A Mutant of 
6-PGDH. 
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4.4 Discussion 
 
The main aim of this research was to determine the importance of residues S128, 
H186, and N187, which interact with both 6PG and NADPH, and their roles in 
providing binding energy and proper orientation of the substrates.  On the basis of 
the crystal structure of the E:6PG and E:NADPH binary complexes, direct and 
indirect interactions between each of the three residues listed and the substrates are 
suggested.  A multiple sequence alignment of 6PGDHs from a variety of species 
from bacteria to man indicates a complete conservation of all of the residues 
considered (Figure 4-3).  Site-directed mutagenesis was used to change S128, H186 
and N187 to alanine one at a time to eliminate the interaction between each of the 
residues and the substrates.  Steady-state kinetic parameters and isotope effects were 
measured to determine the effect of the substitutions on the ability of 6PGDH to use 
6PG and NADPH as a substrate. 
Theory for interpretation of kinetic parameters and isotope effects in the 6PGDH 
reaction has been developed previously and equations are reproduced here for aid in 
data interpretation (10, 14).  The oxidative decarboxylation reaction catalyzed by 
6PGDH is stepwise with oxidation preceding decarboxylation as suggested by 
multiple deuterium/13C kinetic isotope effect studies (14).  Multiple solvent 
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deuterium/13C kinetic isotope effect and proton inventory studies indicate the 
presence of an isomerization of the enzyme complex prior to hydride transfer and 
decarboxylation (23).  The kinetic mechanism of 6PGDH can be written: 
 
EAB
EA
EB
E'AB E'XR E'QR
k3B
k4
k3'A
k4'
k5
k6
k7
k8
k9 [8]
 
 
where A and B represent NADP and 6PG, respectively, and X, Q, and R represent 
3-keto-6PG, ribulose 5-phosphate, and NADPH, respectively.  The rate constants k3 
and k4 are for binding and dissociation of 6PG and k3’ and k4’ are for binding and 
dissociation of NADP, k5 and k6 are for an isomerization of E:NADP:6PG complex, 
k7 and k8 are for forward and reverse hydride transfer, and k9 is the rate constant for 
decarboxylation of the 3-keto intermediate and release of CO2.  A kinetic deuterium 
isotope effect is observed on the hydride transfer step, depicted by Dk7 and Dk8, which 
can be related by the equilibrium isotope effect, DKeq = Dk7 /Dk8, while k9 will reflect a 
13C-kinetic isotope effect given by 13k9. 
Given the rapid equilibrium nature of the mechanism, central complex 
interconversion is rate-limiting (steps included from EAB to E’QR), and thus k4, k4' > 
k5, while k11, k13 > k7.  Finally, since the kinetic isotope effects on V and V/K are 
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equal to one another for the wild type and each of the mutant enzymes, k6 = (1 + 
k6/k5)/(1/k5 + 1/k9). 
The following expressions have been developed. 
 
V =
k7
1+ k6
k5
1+
k7
1
k5
+ 1
k9
 
  
 
  
1+ k6
k5
+ k8
k9
 [9] 
V
K6 PG
=
k3k5k7
k4k6
1+ k7
k6
+ k8
k9
 [10] 
V
KNADP
=
k3'k5k7
k4'k6
1+ k7
k6
+ k8
k9
 [11] 
DV =
Dk7 +
k7
1
k5
+ 1
k9
 
  
 
  
1+ k6
k5
+ DKeq( ) k8k9
 
  
 
  
1+
k7
1
k5
+ 1
k9
 
  
 
  
1+ k6
k5
+ k8
k9
 [12] 
D
V
K6 PG
 
  
 
  =
Dk7 + k7k6
+ DKeq( ) k8k9
 
  
 
  
1+ k7
k6
+ k8
k9
 [13] 
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13
V
K6 PG
 
  
 
  H
=
13k9 + k9 / k8( ) 1+ k7 / k6( )
1+ k9 / k8( ) 1+ k7 / k6( )  [14] 
13
V
K6 PG
 
  
 
  D
=
13k9 + Dk7k9 / k8 DKeq( )1+ k7 / k6 Dk7( )
1+ Dk7k9 / k8 DKeq( )1+ k7 / k6 Dk7( )  [15] 
 
where Dk7 is the intrinsic deuterium isotope effect on the hydride transfer step, and 
DKeq is the equilibrium isotope effect on hydride transfer (1.18 for oxidation of a 
secondary alcohol (24)). 
Since K6PG is the ratio of V and V/K6PG, and KNADP is the ratio of V and V/KNADP 
and taking into account k6 = (1 + k6/k5)/(1/k5 + 1/k9) 
 
K6 PG = k4k3
 
  
 
  
k6
k5 + k6
 
  
 
  = Kd 6 PG  [16] 
KNADP = k4'k3'
 
  
 
  
k6
k5 + k6
 
  
 
  = Kd NADP  [17] 
 
where k4/k3 is the Kd of 6PG and k4’/k3’ is the Kd of NADP for the E:NADP:6PG 
complex and k6/(k5 + k6) corrects for the distribution of the central complexes 
between E:NADP:6PG and E’:NADP:6PG.  Therefore, K6PG is the equilibrium 
constant for dissociation of 6PG from E:NADP:6PG and E’:NADP:6PG and KNADP is 
the equilibrium constant for dissociation of NADP from E:NADP:6PG and 
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E’:NADP:6PG.  Using the above rate equations, we discuss the results for each of 
the mutant enzyme. 
The key to interpretation of the data obtained for the mutant enzymes lies in 
changes in K6PG, D(V/K6PG), 13(V/K6PG) and D2O(V/K6PG)D.  The decrease in K6PG for 
the S128A mutant enzyme likely results from an increase in the net off-rate for 6PG 
from E’:NADP:6PG, k4k6/(k5 + k6).  However, since k6/(k5 + k6) is present in both 
K6PG and KNADP, and no change is observed in the latter for the S128A mutant enzyme, 
it is k4 that is increased.  For the N187A mutant enzyme, the increase in both K6PG 
and KNADP likely results from an increase in the net off-rates for 6PG and NADP from 
E’:NADP:6PG, k4k6/(k5 + k6) (k4'k6/(k5 + k6) in the case of NADP), suggesting an 
increase in k4 and k6. 
4.4.1 The S128A and N187A Mutant Enzymes. 
Both the S128A and the N187A mutant enzymes exhibit an increased K6PG.  
V/Et decreases about 19- and 67-fold, resulting in a V/K6PGEt 65 and 1,300 times 
lower than the wild type protein for the S128A and the N187A mutant enzymes, 
respectively.  In addition, Ki for NADPH for the S128A and N187A mutant enzyme 
increases, suggesting that the mutant enzymes exhibit lower affinity for both 6PG and 
NADPH.  Data are consistent with the structural data of Adams (11), which show 
that the side chains of S128 and N187 interact with 6PG in the E:6PG binary complex 
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and the nicotinamide ring of NADPH in the E:NADPH binary complex. 
The value of 13(V/K6PG) has increased from 1.0028 in the wild type enzyme to 
1.0152 and 1.0209 for the S128A and N187A mutant enzymes, respectively, 
concomitant with a decrease in DV and D(V/K6PG) to a small finite value.  Data 
suggest a decrease in the rate of the decarboxylation step relative to hydride transfer.  
The solvent deuterium isotope effect on V is finite, but smaller than the value of the 
wild type enzyme, while a value of 3.3 is obtained for D2O(V/K6PG)H for the S128A 
mutant enzyme and an inverse D2O(V/K6PG)H for the N187A mutant enzyme. The 
inverse solvent isotope effect may reflect the conformational change prior to hydride 
transfer.  Data are consistent with the observed decrease in 13(V/K6PG) when D2O is 
the solvent. 
V and V/K6PG pH-rate profiles for the S128A mutant enzyme exhibits pK values 
that are closer together than those observed for the wt enzyme, Table 3. (This 
phenomenon was also observed for mutations in the 2'-phosphate subsite and the 
6-phosphate subsite (25, 26).)  The pH-rate profiles reflect reverse protonation states 
between the K183 general base and the E190 general acid (4), and thus the amount of 
active enzyme can be estimated from the antilog of the difference between the acid 
and base pK values.  In the case of the S128A mutant enzyme, the fraction of 
enzyme in the right protonation state is 5%, while in the wide type enzyme the value 
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is 0.5%, representing a 10-fold increase.  The observed V/Et for the S128A mutant 
enzyme, therefore, reflects a 10-fold decreased in the actual value of V/Et. 
4.4.2 The H186A Mutant Enzyme. 
H186 interacts with the nicotinamide ring in the E:NADPH binary complex with 
a hydrogen-bonding distance of 3.2 Ǻ (Figure 3).  In the E:6PG binary complex, the 
side chain of H186 does not interact with the substrate directly, but links the side 
chains of S128 and N187 via two hydrogen bonds as shown in Figure 2.  Therefore, 
smaller changes in the observed kinetic parameters are not unexpected.  Data 
suggest that H186 does not contribute to binding 6PG, but likely helps to position the 
substrate for catalysis. 
The 13C-kinetic isotope effect minus 1 obtained for the H186A mutant enzyme is 
increased by about 3-fold compared to the value of the wild type enzyme, while the 
primary deuterium isotope effect decreases to about 1.5, indicating that the relative 
rate for the decarboxylation step to the hydride transfer step is slower in the mutant 
enzyme.  An inverse solvent deuterium isotope effect in the case of 6PGDH 
normally reflects a medium effect on the conformational change that precedes 
catalysis.  The decrease of the 13C-kinetic isotope effect when measuring in D2O 
indicates that some other step(s) beside the decarboxylation step contribute to rate 
limitation.  In this case, it may be both the conformational change and the following 
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hydride transfer step. 
4.4.3 Roles of the Three Residues. 
All three mutant enzymes exhibit decreased affinity for NADPH, but no change 
in the Km of NADP, with the exception of the N187A mutant enzyme, suggesting that 
the mutant enzymes treat the oxidized and reduced cofactor differently and they only 
help to anchor the cofactor after hydride transfer accompanied by the rotation of the 
nicotinamide ring around the N-glycosidic bond, i.e. S128, H186 and N187 help to 
guide the rotation of the nicotinamide ring.  The measured 13C-kinetic isotope effect 
on all of the mutant enzyme increases compared to the value of the wild type enzyme, 
suggesting that the decarboxylation reaction in the mutant enzymes is not well 
performed as it is in the wild type enzyme, consistent with the proposed non-redox 
role of NADPH.  The S128A and N187A mutant enzymes also exhibit higher Km for 
6PG, suggesting that these two residues also contribute to the binding of 6PG.  
However, the calculated binding energy that each residue contributes is less than that 
of the residues from the 6-phosphate binding site (26), indicating that S128 and N187 
are not as important in providing binding energy for 6PG as residues Y191, 
K260,R287 and R446. 
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Chapter 5 
 
Overall Discussion and Conclusion 
5.1 Overall Discussion and Conclusion. 
    6-Phosphogluconate dehydrogenase has been studied for more than fifty years. 
The mechanism behind the reaction is complicated and the mechanism has been 
refined as new theory and technology has been developed and applied to the study of 
6PGDH. 
The mechanism proposed in 1998 is a general acid-general base catalyzed rapid 
equilibrium random mechanism. The reaction is stepwise with hydride transfer from 
the 3-C of 6PG to the 4-position of the nicotinamide ring of NADP preceding 
decarboxylation of the 3-keto intermediate, as shown in Figure 1-3. There are three 
steps are known to contribute to rate-limitation: a conformational change prior to 
catalysis required to close the active site, exclude water, and bring reactants into 
proximity and alignment, the hydride transfer step and decarboxylation of 
oxaloacetate (1-6). Structural data have shown that the conformation of the 
nicotinamide ring of the cofactor is different in the E:NADP binary complex 
compared to the E:NADPH binary complex (7). Kinetic studies of mutant enzymes 
that have changes at M13, on which the nicotinamide ring of NADP rests, suggest 
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that a rotation of the nicotinamide ring around the glycosidic bond is on the catalytic 
pathway; the mutant enzymes have a lower affinity for the oxidized cofactor but no 
change in affinity for the reduced cofactor (8). Therefore, a modified mechanism has 
been proposed by Cervellati et al., in which the hydride transfer step is accompanied 
by the flip of the nicotinamide ring into the active site (8, Figure 5-1). 
Similar phenomena have been observed in NAD-malic enzyme and 
NAD(P)-dependent aldehyde dehydrogenases (9-13). The hypothesis that the cofactor 
isomerizes after reduction in the malic enzyme is closely aligned to that of 6PGDH, 
with the rotational isomerization suggested to facilitate the next step, decarboxylation, 
by repositioning the substrate. The driving force of the rotation for both 6PGDH and 
malic enzyme is loss of the ionic interaction between the positively charged 
nicotinamide ring of the oxidized cofactor and the negatively charged pyrophosphate 
of the cofactor; a distance of about 5 Ǻ is obtained fro the ionic interaction. Once 
rotation has occurred, the distance increases by about 2 Ǻ. In the case of aldehyde 
dehydrogenases, the theory is somewhat different. After rotation, the nicotinamide 
ring of the cofactor flips away from the active site and make space for deacylation. 
However, in all cases the isomerization is thought to be essential to the catalytic 
mechanism. 
Studies in sheep liver 6PGDH of the residues that interact with the substrate  
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Figure 5-1. The Modified Mechanism of 6-Phosphogluconate Dehydrogenase. 
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and/or cofactor reveal that the 2’-phosphate of NADP is critical for making most of 
the interactions between the protein and the cofactor, helping position the cofactor for 
hydride transfer and participating in the rotational isomerization of the cofactor after 
reduction, probably by holding the cofactor in position so that the nicotinamide ring 
can flip into the right location (14). Destroying the interactions between the 
2’-phosphate and the protein results in a slower or less efficient rotation (the 
nicotinamide ring does not rotate into the right position). The isomerization of the 
cofactor upon reduction is guided by the residues S128, H186 and N187, which 
interact with both 6PG and NADPH. From a dynamic point of view, the rotation of 
the nicotinamide ring may place it in different positions, as evidenced for the mutant 
enzymes when binding affinity of 2’-phosphate is lost or lacks of guidance from S128, 
H186 ad N187. However, only when rotation of the nicotinamide ring can completely 
eliminate the interactions between the 1-carboxylate of 6PG and the protein, will the 
decarboxylation step be catalyzed. Therefore, in the mutant enzyme (N32A, R33A, 
T34A, S128A, H186A and N187A), the observed rate of the decarboxylation step is 
decreased as shown by the large 13C isotope effect. 
On the other hand, the 6-phosphate of 6PG is important in anchoring the 
substrate for catalysis. It is also suggested that occupancy of the 6-phosphate position 
or proper binding of 6PG is critical for the reaction, probably inducing the 
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conformational change in enzyme to close the active site prior to catalysis (15). 
Altering the interactions between the 6-phosphate and the protein results in some 
alteration of the conformational change, but decarboxylation becomes predominantly 
rate-limiting, as a result of a change in the position of 6PG in the site. On the basis of 
the data obtained for the mutant enzymes, a linkage between the cofactor binding site 
and 6PG binding site is suggested (Figure 2-5), because changes in one site have 
effects in the other and no significant global structural change is detected in any of the 
mutant enzymes. 
Combining all the information above together with the previously proposed 
mechanism, we can conclude the essentials in the reaction catalyzed by sheep liver 
6PGDH. 1). Proper binding of both NADP and 6PG is required for the subsequent 
catalytic steps, and a conformational change is induced to close the active site, and to 
bring the two substrates together for catalysis. 2). With the help of K183, proton and 
hydride transfer is performed, and guided by residues S128, H186 and N187, a 
rotation of the nicotinamide ring around the N-glycosidic bond brings the 
carboxamide chain into the position originally occupied by the 1-carboxylate of 6PG 
and the interactions between the 1-carboxylate of 6PG and the enzyme is eliminated. 
3). Decarboxylation is facilitated by K183 and CO2 is released. 4). E190 assists the 
tautomerization step, which converts the enediol intermediate to Ru5P. 5). Binding of 
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NADP and 6PG and releasing of NADPH and Ru5P are random. Overall, the cofactor 
and 6PG binding sites are not isolated, and there is crosstalk between them. 
 
5.2 References. 
 
1. Rendina, A. R. Hermes, J. D. and Cleland, W. W. (1984) Use of Multiple Isotope 
Effects to Study the Mechanism of 6-Phosphogluconate Dehydrogenase. 
Biochemistry 23, 6257-6262. 
 
2. Hwang, C-C., Berdis, A. J., Karsten, W. E., Cleland, W. W. and Cook, P. F. (1998) 
Oxidative Decarboxylation of 6-Phosphogluconate by 6-Phosphogluconate 
Dehydrogenase Proceeds by a Stepwise Mechanism with NADP and APADP as 
Oxidants. Biochemistry 37, 12596-12602. 
 
3. Berdis, A. J. and Cook, P. F. (1993a) Overall Kinetic Mechanism of 
6-Phosphogluconate Dehydrogenase from Candida utilis. Biochemistry 32, 
2036-2040. 
 
4. Price, N. E. and Cook, P. F. (1996) Kinetic and Chemical Mechanism of the Sheep 
Liver 6-Phosphogluconate Dehydrogenase. Arch. Biochem. Biophys. 336, 
215-223. 
 
5. Karsten, W. E., Chooback, L., and Cook, P. F. (1998) Glutamate 190 Is a General 
Acid Catalyst in the 6-Phosphogluconate Dehydrogenase-Catalyzed Reaction. 
Biochemistry 37, 15691-15697. 
 
6. Zhang, L., Chooback, L., and Cook, P. F. (1999) Lysine 183 Is the General Base 
in the 6-Phosphogluconate Dehydrogenase-Catalyzed Reaction. Biochemistry 38, 
11231-11238. 
 
7. Adams, J. M., Grant, H. E., Gover, S., Naylor, C. E., and Philips, C. (1994) 
Substrate Binding in 6-Phosphogluconate Dehydrogenase: Implications for NADP 
Specificity and the Enzyme Mechanism. Structure 2, 651-668. 
 
 138
8. Cervellati, C., Dallocchio, F., Bergamini, C. M., and Cook, P. F. (2005) Role of 
Methionine-13 in the Catalytic Mechanism of 6-Phosphogluconate 
Dehydrogenase from Sheep Liver. Biochemistry 44, 2432-2440. 
 
9. Hammen, P. K., Alliali-Hassani, A., Hallenga, K., Hurley, T. D. and Weiner, H. 
(2002) Multiple Conformations of NAD and NADH When Bound to Cytosolic 
and Mitochondrial Aldehyde Dehydrogenase. Biochemistry 41, 7156-7168. 
 
10. Coleman, D. E., Rao, G. S. J., Goldsmith, E. J., Cook, P. F. and Harris, B. G. (2002) 
Crystal Structure of the Malic Enzyme from Ascaris suum Complexed with 
Nicotinamide Adenine Dinucleotide at 2.3 Ǻ Resolution. Biochemistry 41, 
6928-6938. 
 
11. Perez-Miller, S. J. and Hurley, T. D. (2003) Coenzyme Isomerization Is integral to 
Catalysis in Aldehyde Dehydrogenase. Biochemistry 42, 7100-7109. 
 
12. Rao, G. S. J., Coleman, D. E., Karsten, W. E., Cook, P. F. And Harris, B. G. (2003) 
Crystallographic Studies on Ascaris suum NAD-Malic Enzyme Bound to Reduced 
Cofactor and Identification of an Effector Site. J. Biol. Chem. 278, 38051-38058. 
 
13. D’Ambrosio, K., Pailot, A., Talfournier, F., Didierjean, C., Benedetti, E., Aubry, 
A., Branlant, G. and Corbier, C (2006) The First Crystal Structure of a 
Thioacylenzyme Intermediate in the ALDH Family: New Coenzyme 
Conformation and Relevance to Catalysis. Biochemistry 45, 2978-2986. 
 
14. Li, L and Cook, P. F. (2006) Importance of the 2’-Phosphate of NADP in the 
Sheep Liver 6-Phosphogluconate Dehydrogenase Catalyzed Reaction. 
Biochemistry submitted. 
 
15. Li, L and Cook, P. F. (2006) Importance in Catalysis of the 6-Phosphate Binding 
Site of 6-Phosphogluconate in Sheep Liver 6-Phosphogluconate Dehydrogenase. J. 
Biol. Chem. submitted. 
 139
 
 
 
 
 
Appendix 1 
 
 
 
 
Additional Projects 
 140
1. The M13 and E131 mutations. 
The crystal structure of sheep liver 6-phosphogluconate dehydrogenase shows 
that Met13 and Glu131 interact with the nicotinamide ring of NADP, but not NADPH. 
Recent studies suggest that mutations at Met13 affect NADP, but not NADPH binding, 
consistent with rotation of the nicotinamide moiety of the coenzyme NADP+ when it 
is reduced to NADPH during the course of the catalytic reaction. To further 
corroborate this hypothesis, and to explore the function of Glu131 in the mechanism 
of the 6PGDH reaction, site-directed mutagenesis was performed, changing Glu to 
Ala. The resulting mutant enzyme, E131A, exhibits a 2-fold decrease in V/Et, while 
KNADP, and K6PG remain the same as those of the wild type enzyme (Table A-1). The 
primary deuterium kinetic isotope effect decreases to 1.2, while the 13C-kinetic 
isotope effect minus 1 increases about 2-fold, indicating that the relative rate of the 
decarboxylation step compared to the hydride transfer step decreases in the E131A 
mutant enzyme (Table A-2). 13C-kinetic isotope effects were also measured for three 
of Met13 mutant enzymes, M13V, M13Q and M13C (Table A-2). As a result, all of 
the mutant enzymes exhibit an increased 13C-kinetic isotope effect with the exception 
of the M13Q mutant enzyme. A manuscript describing these data is in preparation 
(University of Oklahoma, USA and Università di Ferrara, Italy). 
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 E131A 
V/Et (sec-1) 
Fold decrease 
KNADP (µM) 
Fold increase 
K6PG (µM) 
Fold increase 
4.0 ± 0.4 
2 
5 ± 1 
- 
14 ± 3 
- 
Table A-1. Kinetic Parameters of The E131A Mutant Enzyme. 
 
 
 E131A M13V M13Q M13C 
DV 
D(V/K6PG) 
13(V/K6PG)H 
 
13(V/K6PG)D 
 
1.2 ± 0.1 
1.1 ± 0.2 
1.0046 
(0.0003)b 
- 
- 
 
 
1.0062 
(0.0004) 
1.0037 
(0.0008) 
 
 
1.0033 
 (0.0009) 
0.998 
(0.001) 
 
 
1.0151 
(0.0002) 
1.014 
(0.002) 
Table A-2. Summary of Isotope Effects for 6PGDH Mutant Enzymesa  
aValues are ± S.E. 
bValues in parenthesis are standard errors for the 13C-kinetic isotope 
effects. 
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2. The Pre-steady State Studies on the Y191A, K260A and T262A Mutant 
Enzymes. 
As discussed in Chapter 3, the Y191A, K260A and T262A mutant enzymes 
exhibit a dramatic decrease in the rate of the decarboxylation step, which becomes 
predominantly rate-limiting in the overall reaction, especially for the last two 
mutant enzymes. Therefore, pre-steady state kinetic studies have been carried out 
using stopped-flow spectrophotometry. 
Preliminary data show a burst (accumulation of NADPH) followed by a linear 
steady state rate for the K260A and T262A mutant enzymes, while the Y191A 
mutant enzyme does not exhibit a burst (Figure A-1). Data suggest the 
decarboxylation step is much slower in the K260A and T262A mutant enzyme than 
it is in the Y191A mutant enzyme, consistent with the previously measured 
13C-kinetic isotope effects. Further experiments, including protein concentration 
dependence of the burst and isotope effect studies are needed to confirm the 
accumulation of NADPH results from a decreased rate of the decarboxylation step. 
In addition, a quantitative analysis of the data will provide information on the 
relative rates of steps within the catalytic pathway. 
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Figure A-1. The Pre-Steady State Studies of Y191A, K260A and T262A. 
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3. Subcloning Enzymes in the α-Aminoadipate Pathway  
The α-aminoadipate pathway is a lysine biosynthetic pathway unique to fungi 
(1, Figure A-2). In addition to the enzymes that are actively being investigated in 
the lab, there are four enzymes we are interested in. They are homoisocitrate 
dehydrogenase (HICDH or Lys 10)), homoaconitase (HAT or Lys 4), alpha 
aminoadipate reductase (AAR), and the small subunit of AAR, 
phosphopantetheinyl transferase or Lys5. The genes of Lys10, Lys4, Lys2 and Lys5 
from Saccharomyces cerevisiae genomic DNA have been amplified by using PCR 
(Figure A-3). Thus far, Lys 10, Lys 4, and Lys 5 have been subcloned into the 
pET-16b vector successfully. Dr. Ying Lin has taken over this project, has 
expressed and is characterizing Lys10. 
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Figure A-2. The Lysine Biosynthetic Pathway in Saccharomyces cerevisiae. 
The enzymes of the lysine AAA biosynthetic pathway are as follows: (1) 
Homocitrate synthase (HCS, E.C. 4.1.3.21), (2) Homoaconitase (HAc, 
E.C. 4.2.1.36), (3) Homoisocitrate dehydrogenase (HIDH, E.C. 
1.1.1.87), (4) α-aminoadipate aminotransferase (AAT, E.C. 2.6.1.39), (5) 
α-aminoadipate reductase (AAR, E.C. 1.2.1.31), (6) Saccharopine 
reductase (SR, E.C. 1.5.1.10), (7) Saccharopine dehydrogenase (SDH, 
E.C. 1.2.1.31). 
 146
 
 
 
 
Figure A-3. PCR for the Lys5, HICDH, HAT and AAR from Saccharomyces 
cerevisiae. The sizes of the genes of Lys, HICDH, HAT and AAR are 
819bp, 1116bp, 2082bp and 4199bp, respectively. 
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Figure A-4. NMR Spectra of 3-h-6PH and 3-d-6PG. The top panel is the NMR 
spectrum of 3-d-6PG and the bottom is the NMR spectrum of the 
3-h-6PH. 
